Guidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0)
Open accessAbstract
Good Cell and Tissue Culture Practice (GCCP) 2.0 is an updated guidance document from GCCP 1.0 (published by ECVAM in 2005), which was developed for practical use in the laboratory to assure the reproducibility of in vitro (cell-based) work. The update in the guidance was essential as cell models have advanced dramatically to more complex culture systems and need more comprehensive quality management to ensure reproducibility and high-quality scientific data. This document describes six main principles to consider when performing cell culture including characterization and maintenance of essential characteristics, quality management, documentation and reporting, safety, education and training, and ethics. The document does not intend to impose detailed procedures but to describe potential quality issues. It is foreseen that the document will require further updates as the science and technologies evolve over time.
Verified 2026-10-07 · 1 reference not checked yet
AI snapshot
Written from the paper’s full text.
TL;DR
GCCP 2.0 is an updated expert guidance document for good cell and tissue culture practice, revising the 2005 GCCP 1.0. It sets out six principles to improve reproducibility, quality, safety, ethics, documentation, and training for in vitro cell-based work, including complex culture systems.
Key findings
- The guidance is organized around six operational principles: understanding the cell culture system; quality management; documentation and reporting; safety; compliance with laws and ethical principles; and education/training.
- It introduces and elaborates GCCP acceptance criteria (GAC) for cell culture status and composition, defined by the parameter assessed, method of quantification, and acceptable range.
- It extends guidance to complex systems such as pluripotent stem cells, 3D cultures, organotypic cultures, microphysiological systems, and organ-on-a-chip systems, noting these may require additional quality control and GAC.
- It recommends practices including cell authentication, mycoplasma testing, master/working cell banks, careful documentation, and avoidance of routine antibiotics except in justified cases.
Methods
- This is a guidance document, not an experimental study; it was developed through expert review and consensus, with a Steering Committee and Scientific Advisory Committee under CAAT and stakeholder feedback incorporated into the final document.
- It synthesizes prior GCCP 1.0 (2005), the OECD GIVIMP guidance (2018), and expert input; no primary data collection, sample, or statistical analysis is reported.
- The main content is a narrative description of the six GCCP principles, supported by tables and appendices on documentation, quality control, safety, and training.
Limitations
- Stated: the document does not intend to impose detailed procedures but to describe potential quality issues; it is foreseen to require further updates as science and technologies evolve.
- Stated: its scope excludes the development and implementation of cell- and tissue-based methods, which are directed to GIVIMP; deviations from specific elements may be necessary and should be justified.
- Stated: many principles can apply to non-mammalian cells, but additional considerations may be needed. Evident from the text: the guidance is consensus-based and context-dependent, without empirical validation or quantitative synthesis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
10 of 117 cited sources checked · 3 supported · 0 flagged · accuracy not yet measured
- Findingcitation§ 1.1.4.1 Direct reprogramming of cells and tissues · p. 6
Direct reprogramming of primary and passaged cells towards specific terminally differentiated cell derivatives has been shown to be a promising approach to obtain cell cultures of interest while avoiding the need to establish stable PSC lines and develop differentiation protocols.
“Direct reprogramming of primary and passaged cells towards specific terminally differentiated cell derivatives has also been shown to be a promising approach to obtain cell cultures of interest (Zhang and Jiang, 2015) while avoiding the need to establish stable PSC lines and develop differentiation protocols.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zhang and Jiang, 2015
Not checked in the free run.
- Findingcitation§ 1.1.3.1 Finite cell lines · p. 5
Changes occur in finite cell lines as they approach senescence.
“However, changes occur as they approach senescence, and they should not be used above the defined population doubling limits that can be established by experimental investigation (Hayflick, 1965).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hayflick, 1965
Not checked in the free run.
- Findingcitation§ 1.1.3.2 Continuous cell lines · p. 5
While some continuous cell lines appear to be stable over long-term passage in vitro, they often undergo substantial genetic changes.
“While some continuous cell lines appear to be stable over long-term passage in vitro , they often undergo substantial genetic changes (Geraghty et al., 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Geraghty et al., 2014
Not checked in the free run.
- Findingcitation§ 1.1.3.2 Continuous cell lines · p. 5
An authenticated cell line can evolve in cell culture so that the same cell line obtained from different laboratories can display different properties, including genetic heterogeneity.
“An authenticated cell line can evolve in cell culture so that the same cell line obtained from different laboratories can display different properties, including genetic heterogeneity (Ben-David et al., 2018; Liu et al., 2019; Kleensang et al., 2016).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Ben-David et al., 2018
Not checked in the free run.
- cites Liu et al., 2019
Not checked in the free run.
- cites Kleensang et al., 2016
Not checked in the free run.
- Premisecitation§ 1.1.4.2 Genome editing and gene expression regulation · p. 6
The proposed constructs and their locations in the genome can impact the intended functionality and utility of genetically modified cells, for example by altering constitutive expression of reprogramming factors in PSCs or silencing a reporter gene.
“In the development of these lines, it is important to consider whether the proposed constructs and their locations in the genome would be likely to impact the intended functionality and utility of the cells (for a review, see Stepanenko and Heng, 2017), altering, for example, the constitutive expression of reprogramming factors in PSCs or silencing a reporter gene that is supposed to remain active”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Stepanenko and Heng, 2017
Not checked in the free run.
- Interpretationreasoning§ 1.1.3.2 Continuous cell lines · p. 5
The evolution of an authenticated cell line in culture can lead to a lack of reproducibility and comparability when working with the same cell line in different laboratories.
“This can lead to a lack of reproducibility and comparability when working with the same cell line in different laboratories.”
Quote in the paperSubstantial claim- Rests on an assumption: Reproducibility of in vitro (cell-based) work is important and desirable.
- Premisecitation§ 1.3.2.2 Atmosphere · p. 9
The height/level of medium above cells determines the accessibility to oxygen and should be recognized as an important factor for cell culture.
“In addition, the height/level of medium above cells determines the accessibility to oxygen and should be recognized as an important factor for cell culture (Al-Ani et al., 2018).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Al-Ani et al., 2018
Not checked in the free run.
- Premisecitation§ 1.5 Cryopreservation, storage, and shipping · p. 10
Cells and tissues can be cryopreserved in a stable state for limited or prolonged periods.
“Cells and tissues can be cryopreserved in a stable state for limited or prolonged periods (Baust et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Baust et al., 2017
Not checked in the free run.
- Premisecitation§ 1.3.2.2 Atmosphere · p. 9
The use of closed cell handling chambers to provide constant physiologically relevant oxygen can improve cell function.
“The use of closed cell handling chambers to provide constant physiologically relevant oxygen can improve cell function (Mount et al., 2019; Wong et al., 2020).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Mount et al., 2019
Not checked in the free run.
- cites Wong et al., 2020
Not checked in the free run.
- Premisecitation§ 1.2.1 Cell identity · p. 7
Cross-contamination between different cell lines is a serious but often neglected problem.
“Cross-contamination between different cell lines is a serious but often neglected problem (Nelson Rees et al., 1981).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nelson Rees et al., 1981
Not checked in the free run.
- Premisecitation§ 2.2.1 Cells and tissues · p. 12
Commonly used genomic integrity tests include targeted assays (FISH and PCR-based nucleic acid quantification approaches, such as quantitative real-time PCR and digital PCR), as well as whole genome assays (G-banding karyotyping, chromosomal microarray and massive parallel sequencing).
“Commonly used genomic integrity tests include targeted assays (fluorescence in situ hybridization (FISH) and PCR-based nucleic acid quantification approaches, such as quantitative real-time PCR and digital PCR), as well as whole genome assays (G-banding karyotyping, chromosomal microarray and massive parallel sequencing) (MacLeod and Drexler, 2005; Capes-Davis et al., 2010; Dirks et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites MacLeod and Drexler, 2005
Not checked in the free run.
- cites Capes-Davis et al., 2010
Not checked in the free run.
- cites Dirks et al., 2009
Not checked in the free run.
- Premisecitation§ 1.3.2.2 Atmosphere · p. 9
Native tissue oxygen concentrations can be between 1-5%.
“It is known that native tissue oxygen concentrations can be between 1-5% (Ottosen et al., 2006; Wenger et al., 2015; Keeley and Mann, 2019).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Ottosen et al., 2006
Not checked in the free run.
- cites Wenger et al., 2015
Not checked in the free run.
- cites Keeley and Mann, 2019
Not checked in the free run.
- Premisecitation§ 1.3.1.3 Nutritional status · p. 8
Different medium supply schemes such as static, perfusion or periodical may influence the proliferation characteristic of the cells.
“Different medium supply schemes such as static, perfusion or periodical may also influence the proliferation characteristic of the cells (Gilbert et al., 2019).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gilbert et al., 2019
Not checked in the free run.
- Premisecitation§ 1.2.2 Stability of in vitro culture · p. 7
Genetic and epigenetic variants are known to arise in the derivation of a cell line and during cell culture expansion, notably in cancer cell lines and PSCs.
“Genetic and epigenetic variants are known to arise in the derivation of a cell line and during cell culture expansion, notably in cancer cell lines and PSCs (Rebuzzini et al., 2016).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rebuzzini et al., 2016
Not checked in the free run.
- Premisecitation§ 4.2.3 Biological hazards · p. 29
For cells intended for transplantation, there are established requirements for donor selection, processing, testing, storage, and supply.
“In the case of cells intended for transplantation, there are established requirements for donor selection, processing, testing, storage, and supply (EU, 2006a; FDA, 2001).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites EU, 2006a
Not checked in the free run.
- cites FDA, 2001
Not checked in the free run.
- Premisecitation§ 4.2.3 Biological hazards · p. 28
Cells and tissues have the potential to permit the replication of viruses that are pathogenic to humans.
“cells and tissues have the potential to permit the replication of viruses that are pathogenic to humans (occasionally with tragic consequences (Zhang et al., 2010; Lloyd et al., 1984))”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Zhang et al., 2010
Not checked in the free run.
- cites Lloyd et al., 1984
Not checked in the free run.
- Interpretationreasoning§ 2.3.1 Definition and rationale · p. 16
Introduction of increasingly prescriptive procedures or SOPs does not solve the problem of defining the suitability of cells for a given experimental purpose.
“Introduction of increasingly prescriptive procedures or SOPs does not solve the problem of defining the suitability of cells for a given experimental purpose.”
Quote in the paperNot a substantial claim - Premisecitation§ 4.2.3 Biological hazards · p. 28
Human and primate cells, including hESCs and iPSCs, are considered of highest risk of carrying human pathogens.
“In general, human and primate cells (including hESCs and iPSCs) are considered of highest risk of carrying human pathogens (Stacey and Hawkins, 2017)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stacey and Hawkins, 2017
Not checked in the free run.
- Premisecitation§ 4.2.3 Biological hazards · p. 28
Cells from species other than humans and primates can also harbor serious human pathogens.
“although it is important to bear in mind that cells from other species can also harbor serious human pathogens (Stacey, 2007; Mahy et al., 1991; Petricciani et al., 2017).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Stacey, 2007
Not checked in the free run.
- cites Mahy et al., 1991
Not checked in the free run.
- cites Petricciani et al., 2017
Not checked in the free run.
- Premisecitation§ 4.2.3 Biological hazards · p. 28
For all sources of cells, the availability of data from microbiological screening tests helps mitigate risk.
“For all sources of cells, the availability of data from microbiological screening tests will help mitigate risk”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Frommer et al., 1993
Not checked in the free run.
- cites Fountain et al., 1997
Not checked in the free run.
- Premisecitation§ RNAi expression inhibition, and gene editing · p. 19
Constitutive CMV-based promoters drastically change activity during differentiation of LUHMES cells.
“As examples, constitutive CMV-based promoters drastically change activity during differentiation of LUHMES cells (Scholz et al., 2018; Schildknecht et al., 2013)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Scholz et al., 2018
Not checked in the free run.
- cites Schildknecht et al., 2013
Not checked in the free run.
- Premisecitation§ 3.2.2 Subcultivation of cells · p. 24
PDLs can be calculated from the numbers of cells seeded and harvested, with an adjustment for plating efficiency of the cell culture and the specific culture medium used, to accurately document culture age.
“To accurately document culture 'age,' the numbers of cells seeded and harvested will enable PDLs to be calculated, with an adjustment for plating efficiency of the cell culture and the specific culture medium used (Masters and Stacey, 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Masters and Stacey, 2007
Not checked in the free run.
- Premisecitation§ 4.2.3 Biological hazards · p. 28
Culture and storage history may be useful in flagging potential hazards from reagents and costored materials.
“the culture and storage history may be useful in flagging potential hazards from reagents and costored materials (Frommer et al., 1993; Fountain et al., 1997).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Frommer et al., 1993
Not checked in the free run.
- cites Fountain et al., 1997
Not checked in the free run.
- Premisecitation§ 7 Conclusions · p. 34
The development of the seminal GCCP guidance document has strongly contributed to a higher quality assurance of cell culture work.
“The development of the seminal GCCP guidance document (Coecke et al., 2005) has strongly contributed to a higher quality assurance of cell culture work.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Coecke et al., 2005
Not checked in the free run.
- Premisecitation§ 5.2 Use of human cells and tissues · p. 32
There may be controls and, in some cases, prohibition on the procurement and use of the original donor tissues or cells, as well as on the generation and use of cell lines from these materials.
“There may be controls and, in some cases, prohibition on the procurement and use of the original donor tissues or cells, as well as on the generation and use of cell lines from these materials (Seltmann et al., 2016; Andrews et al., 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Seltmann et al., 2016
Not checked in the free run.
- cites Andrews et al., 2015
Not checked in the free run.
- Premisecitation§ 5.2 Use of human cells and tissues · p. 32
Requirements for acceptable informed consent may vary between and even within legal jurisdictions.
“Requirements for acceptable informed consent may vary between and even within legal jurisdictions, and the investigator obtaining the tissues must ensure compliance with all applicable laws, regulations, and local rules, e.g., the US NCCUSL Revised Uniform Anatomical Gift Act (NCCUSL, 2006), the UK Human Tissues Act (UK, 2004), EU regulations comprising three EC Directives: the parent Directive 20”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites NCCUSL, 2006
Not checked in the free run.
- cites UK, 2004
Not checked in the free run.
- cites Pirnay et al., 2015
Not checked in the free run.
- Classified as probably not a substantial claim. 67
- May combine two claims. 47
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingcitation§ 1.1.4.2 Genome editing and gene expression regulation · p. 6Genome editing is particularly relevant in the study of monogenic diseases, for which the genes responsible for disease etiology are known.
“This is particularly relevant in the study of monogenic diseases, for which the genes responsible for disease etiology are known (Pamies et al., 2018).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Pamies et al., 2018 source
May combine two claims.
Findingcitation§ 1.1.2 Primary cultures and their passaged derivatives · p. 5Primary cultures commonly require specific set-ups and complex nutrient media, incorporating ill-defined and variable supplements such as serum.
“They commonly require specific set-ups (Foty, 2011) and complex nutrient media, incorporating ill-defined and variable supplements (such as serum).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Foty, 2011 source
The Discussion (page unavailable) describes other 3D spheroid methods using simulated microgravity incubators or micro-molded hydrogels, supporting the narrower point that some methods need specific set-ups. It does not establish that primary cultures commonly require them; it says the paper’s own hanging-drop method needs no specialized equipment. The citation is attached to the set-up claim, not the subsequent statement about nutrient media. (LLM, conf=0.82)
Experimental — accuracy not yet measured
May combine two claims.
Findingcitation§ 1.1.4.2 Genome editing and gene expression regulation · p. 6CRISPR-Cas9 impacts on quality include an undefined level of off-target effects of designer nucleases, purity of the Cas-9 protein, constitutive expression of Cas-9, genetic stability of edited clones, and retention of wild-type cells.
“As an example of the most commonly used technique, CRISPR-Cas9 impacts on quality include: an undefined level of off-target effects of designer nucleases, purity of the Cas-9 protein, constitutive expression of Cas-9, genetic stability of edited clones, and retention of wild-type cells (Hendriks et al., 2016).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Hendriks et al., 2016 source
The sections on CRISPR guide design and the Concluding remarks identify off-target cutting as a concern and say sustained Cas9 expression can exacerbate nuclease activity. The section on genome-edited cell selection warns that merged colonies can produce mixed genotypes, while the paper also discusses mutations accumulated during cell culture. Our copy does not identify Cas9 protein purity or specifically the retention of wild-type cells as quality concerns, and it does not characterize off-target effects as having an undefined level. Page numbers are unavailable in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
Premisecitation§ 1.2.1 Cell identity · p. 7The same cell line may be referred to by different names by different authors, and differing cell lines have also been called the same name.
“The same cell line may be referred to by different names by different authors, and differing cell lines have also been called the same name (Luong et al., 2011).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Luong et al., 2011 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ 1.6 Microbial and viral contaminations · p. 10The most common examples of such infections are environmental bacteria, fungi, and mycoplasma, the latter arising most frequently from new cell lines introduced to the laboratory.
“The most common examples of such infections are environmental bacteria, fungi, and mycoplasma, the latter arising most frequently from new cell lines introduced to the laboratory (Drexler and Uphoff, 2002).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Drexler and Uphoff, 2002 source
The Introduction identifies microorganisms, particularly mycoplasma, as a common cell-line contamination problem. The Sources of mycoplasma contamination section calls infected cell lines the single most important source of further spread, but does not say that newly introduced lines are the most frequent origin. The passages do not establish environmental bacteria and fungi as the other most common infections. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
Premisecitation§ 1.2.2 Stability of in vitro culture · p. 7Such genetic changes appear to occur at any time during passage and may be associated with culture conditions such as medium acidification, frequent single cell dissociation, or repeated use of Rho kinase inhibitors.
“Such changes appear to occur at any time during passage (International Stem Cell Initiative, 2011) and may be associated with culture conditions - such as medium acidification - as a consequence of suboptimal culturing and passaging (e.g., frequent single cell dissociation) or the repeated use of Rho kinase inhibitors (Assou et al., 2018; Jacobs et al., 2016).”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites International Stem Cell Initiative, 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Assou et al., 2018 source
In ‘Classification According to the Cause’ (page not provided), the review links suboptimal culture and single-cell passaging to genomic abnormalities. Our copy does not link medium acidification or repeated use of Rho kinase inhibitors to those changes; its mention of ROCK concerns apoptosis during single-cell dissociation. The ‘any time during passage’ clause is attributed to a different citation in the printed sentence. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites Jacobs et al., 2016 source
The Results section reports that medium acidification caused by lactate accumulation was a key factor in DNA damage in high-density hESC cultures; the Discussion links suboptimal culture conditions to genomic instability. The paper does not establish frequent single-cell dissociation or repeated Rho kinase inhibitor use as causes. The claim about changes occurring at any time during passage is cited to a different source, not Jacobs et al. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 1.6 Microbial and viral contaminations · p. 10A number of human cell lines appear to be infected with viruses, including human pathogens such as HTLV-2.
“A number of human cell lines appear to be infected with viruses, including human pathogens such as HTLV-2 (Uphoff et al., 2019).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Uphoff et al., 2019 source
The Results and discussion (page unavailable) identify cell lines with PCR-confirmed viral infections, supporting the general claim. But the two cell lines with HTLV-2-specific reads had only one and 16 reads; the paper treats similarly low-level viral reads as possible processing contamination, not evidence that those cell lines were infected with HTLV-2. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
Premisecitation§ 2.2.6 Data management · p. 16When importing text files of transcriptome data into a spreadsheet program, gene symbols may be wrongly imported as dates, which can lead to erroneous conclusions about the affected genes.
“For example, when importing text files of transcriptome data into a spreadsheet program, gene symbols may be wrongly imported as dates (Zeeberg, 2004; Ziemann, 2016), which can lead to erroneous conclusions about the affected genes.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites Zeeberg, 2004 source
- cites Ziemann, 2016 source
The Abstract states that Excel converts gene names to dates, and the electronic supplementary material documents such errors in genomics gene lists and warns that the affected files are frequently reused. The copy does not specifically describe importing transcriptome text files or show that the errors lead to erroneous conclusions about the affected genes. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone given§ 1.1.2 Primary cultures and their passaged derivatives · p. 5Primary cultures are typically composed of heterogeneous cell populations and are difficult to standardize and to reproduce because of variation between preparations, supplements, and donors.
“Primary cultures are typically composed of heterogeneous cell populations and are difficult to standardize and to reproduce because of variation between preparations, supplements, and donors.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone given§ 1.1.3.2 Continuous cell lines · p. 5Continuous cell lines do not show the senescence experienced with finite cell lines, as they evade natural ageing processes as observed in cancer cells.
“They do not show the senescence experienced with finite cell lines, as they evade natural ageing processes as observed in cancer cells.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingcitation§ 1.1.4.1 Direct reprogramming of cells and tissues · p. 6The use of direct reprogramming as a source of routine cell supply for experimentation is an area in expansion.
“The use of direct reprogramming as a source of routine cell supply for experimentation is an area in expansion (Xu et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Xu et al., 2015
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingnone given§ 1.1.1 Isolated organs and tissues · p. 5Isolated organs and tissues are difficult to standardize because they often have complex environmental and nutritional needs and because of biological and experimental variables between donors and manipulation procedures.
“These systems are difficult to standardize because they often have complex environmental and nutritional needs and because of biological and experimental variables between donors and manipulation procedures.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingcitation§ 1.1.4.2 Genome editing and gene expression regulation · p. 6RNAi technologies (such as siRNA or shRNA) may have an impact on the induction of the cellular anti-viral response, which may confound the interpretation of downstream experimental data.
“It should also be considered that RNAi technologies (such siRNA or shRNA) may have an impact on the induction of the cellular anti-viral response (Berkhout, 2018), which may confound the interpretation of downstream experimental data.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Berkhout, 2018 source
Checked before — its earlier verdict is held back until a new check runs.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone given§ 1.1.3.2 Continuous cell lines · p. 5Physical and molecular techniques have been developed to stimulate primary cells to replicate indefinitely.
“However, physical and molecular techniques have been developed to stimulate primary cells to replicate indefinitely.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingnone given§ 1.1.4.2 Genome editing and gene expression regulation · p. 6The application of gene editing still requires careful quality control and is associated with several uncertainties, including off-target effects on genome integrity, indirect effects through chromatin remodeling, and unintentional changes of the primary genetic code.
“However, the application of gene editing still requires careful quality control and is associated with several uncertainties (e.g., off-target effects on genome integrity, indirect effects through chromatin remodeling, unintentional changes of the primary genetic code, etc.).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone given§ 1.1.4.2 Genome editing and gene expression regulation · p. 6RNAi technologies are based on the introduction of double-stranded RNA (dsRNA) into the cytoplasm, which triggers the cell to down-regulate certain RNAs.
“RNAi technologies are based on the introduction of double-stranded RNA (dsRNA) into the cytoplasm, which triggers the cell to down-regulate certain RNAs.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingcitation§ 1.1.3.1 Finite cell lines · p. 5Finite cell lines can have a lifespan of up to 70 population doublings in vitro.
“Finite cell lines can have a lifespan of up to 70 population doublings in vitro .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hayflick, 1965 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingcitation§ 1.1.4.2 Genome editing and gene expression regulation · p. 6There is now a range of genome- and epigenome-editing techniques, as well as regulation of gene expression by knock-out/in and RNA interference (RNAi) techniques or introduction of other genetic vectors.
“There is now a range of genome- and epigenome-editing techniques (reviewed by Pamies et al., 2018), as well as regulation of gene expression by knock-out/in and RNA interference (RNAi) techniques or introduction of other genetic vectors.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pamies et al., 2018 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone given§ 1.1.4 Cell modification · p. 6Isolated primary cells and cell lines can be subjected to modification other than immortalization, which may alter cell genetics and function.
“Isolated primary cells and cell lines can be subjected to modification other than immortalization, which may alter cell genetics and function.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingreasoning§ 1.1.4.2 Genome editing and gene expression regulation · p. 6Due to its specificity and simplicity, RNAi is now widely used to knock down the expression of specific genes.
“Due to its specificity and simplicity, this approach is now widely used to knock down the expression of specific genes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone given§ 1.1.2 Primary cultures and their passaged derivatives · p. 5Primary cultures generally have a limited lifespan and are known to change important features with time in culture.
“However, they generally have a limited lifespan and are known to change important features with time in culture.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone given§ 1.1.4.2 Genome editing and gene expression regulation · p. 6Gene silencing tools may cause unintended or off-target effects such as induction of anti-viral responses that can impact on experimental data.
“Furthermore, it is important to recognize that gene silencing tools may cause unintended or off-target effects such as induction of anti-viral responses that can impact on experimental data.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone given§ 1.1.1 Isolated organs and tissues · p. 5The lifetime of isolated organs and tissues is limited, and characteristics can be rapidly lost with culturing time in vitro.
“Furthermore, the lifetime of these systems is limited, and characteristics can be rapidly lost with culturing time in vitro .”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone given§ 1.1.1 Isolated organs and tissues · p. 5Isolated organs and tissues are popular due to their similarity to the in vivo (physiological) tissue.
“Such in vitro systems are popular due to their similarity to the in vivo (physiological) tissue.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone given§ 1.1.3.1 Finite cell lines · p. 5Many finite cell lines have been established from human fibroblasts, which may remain diploid for many passages.
“Many finite cell lines have been established from human fibroblasts, which may remain diploid for many passages.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone given§ 1.1.2 Primary cultures and their passaged derivatives · p. 5Primary cultures in many cases exhibit key characteristics similar to those seen in vivo; thus, they are widely used for basic research and other in vitro applications.
“In many cases, such cultures exhibit key characteristics similar to those seen in vivo ; thus, they are widely used for basic research and other in vitro applications.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Findingnone given§ 1.1.3.2 Continuous cell lines · p. 5Historically, continuous cell lines have been typically derived from tumors or normal embryonic tissues.
“Historically, continuous cell lines have been typically derived from tumors or normal embryonic tissues.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Findingnone given§ 1.1.4.2 Genome editing and gene expression regulation · p. 6In the development of genome editing technologies used in disease modelling and drug development, a panel of techniques has been established (TALENS, CRISPR-Cas9 and Zinc-finger techniques), each one presenting different strengths for particular applications.
“In the development of genome editing technologies used in disease modelling and drug development, a panel of techniques has been established (i.e., TALENS, CRISPR-Cas9 and Zinc-finger techniques), each one presenting different strengths for particular applications.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingcitation§ 1.1.3.1 Finite cell lines · p. 5Finite cell lines undergo a programmed process of biological 'ageing' and eventually cease replication and enter a state of senescence.
“Finite cell lines are cultures of cells that can be sub-cultured many times but undergo a programmed process of biological 'ageing' (Campisi and di Fagagna, 2007) and eventually cease replication and enter a state of senescence (Shay and Wright, 2000; Swim and Parker, 1957).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Findingreasoning§ Laws and regulations · p. 36The GCCP 2.0 document received broad-ranging input from many fields.
“In conclusion, this document is a comprehensive guidance document that has received broad-ranging input from many fields and provides the necessary information to promote the generation of good-quality reproducible data, facilitate inter-laboratory comparability, and to help overcome possible problems intrinsic to cell culture work.”
Quote in the paperNot a substantial claim- Rests on an assumption: Acceptance among different scientists in the field is key for an optimal implementation of the guidance document.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone given§ 1.1.4.2 Genome editing and gene expression regulation · p. 6Genome- and epigenome-editing and gene expression regulation technologies facilitate studies of the role of genes in normal and disease states by intervening on the state or expression level of specific genes.
“These technologies facilitate studies of the role of genes in normal and disease states by intervening on the state or expression level of specific genes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationreasoning§ 1.1.4.2 Genome editing and gene expression regulation · p. 6Unintended or off-target effects of gene silencing tools can be controlled by use of more than one RNA sequence for a single target.
“This can be controlled by use of more than one RNA sequence for a single target.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S4 (based).
Interpretationreasoning§ 1 Principle 1: Understanding your cell culture system and factors that affect it · p. 4By establishing a framework of understanding and control procedures for certain factors, reproducibility, relevance, and reliability can be optimized.
“However, by establishing a framework of understanding and control procedures for certain factors, reproducibility, relevance, and reliability can be optimized.”
Quote in the paperNot a substantial claim- Rests on an assumption: Reproducibility of in vitro (cell-based) work is important and desirable.
May combine two claims.
Interpretationreasoning§ 1.1.5 Complex culture systems · p. 7Complex culture systems may exhibit features not previously observed when the same cells are cultured using standard methods, which could impact required media composition, culture controls, measurements for monitoring/suitability, laboratory safety issues, and safety of recipients of medicinal products.
“Thus, complex systems may exhibit features not previously observed when the same cells are cultured using standard methods, which could impact on the required media composition, culture controls (e.g., gas, nutrients, catabolites), measurements required for culture monitoring/suitability (e.g., morphology/structure, cell enumeration, function), even laboratory safety issues (e.g., reactivation of”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone given§ 1 Principle 1: Understanding your cell culture system and factors that affect it · p. 4There are three fundamental elements for assuring reliable, relevant, and accurate work when using cell- and tissue-based systems: authenticity, purity, and stability and functional integrity.
“There are three fundamental elements for assuring reliable, relevant, and accurate work when using cell- and tissue-based systems, which are:”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone given§ 1.1.3.2 Continuous cell lines · p. 5Each intervention to achieve continuous cell lines brings benefits but may also affect how closely the resulting in vitro model matches in vivo responses.
“Each intervention to achieve this brings benefits but may also affect how closely the resulting in vitro model matches in vivo responses, as described in Appendix 1 1 .”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ 1.1.4.2 Genome editing and gene expression regulation · p. 6The analysis of several gene-edited clones and their functional derivatives or the creation of isogenic control cells can help resolve quality issues of CRISPR-Cas9 editing.
“The analysis of several gene-edited clones and their functional derivatives or the creation of isogenic control cells can help resolve these issues.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone given§ 1 Principle 1: Understanding your cell culture system and factors that affect it · p. 4Chief amongst the factors affecting reproducibility, relevance, and reliability is the availability of well-characterized and quality-controlled stocks of cells and tissues, media, and other critical reagents, as well as openly accessible defined procedures documenting all procedural steps taken.
“Chief amongst these factors is the availability of well-characterized and quality-controlled stocks of cells and tissues, media, and other critical reagents, as well as openly accessible defined procedures documenting, in detail, all the procedural steps taken.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone given§ 1.1.4.2 Genome editing and gene expression regulation · p. 6The quality of the models generated by genome editing techniques may depend on a variety of factors explored in Principle 2.
“The quality of the models generated by these techniques may depend on a variety of factors explored in Principle 2 (see 2.3).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ 2.2.1 Cells and tissues · p. 12DNA profiling can be carried out in-house or by service providers with the ability to compare STR results between organizations.
“DNA profiling can be carried out in-house or by service providers with the ability to compare STR results between organizations (International Stem Cell Banking Initiative, 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites International Stem Cell Banking Initiative, 2009
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Premisecitation§ 1.5 Cryopreservation, storage, and shipping · p. 10Where there is multi-user access, any storage system will be prone to temperature cycling, which is known to reduce viability, and the failure of routine liquid nitrogen refilling procedures can result in the catastrophic loss of viability of stored materials.
“Where there is multi-user access, any storage system will be prone to temperature cycling, which is known to reduce viability (Angel et al., 2016), and the failure of routine liquid nitrogen refilling procedures can result in the catastrophic loss of viability of stored materials.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Angel et al., 2016 source
Checked before — its earlier verdict is held back until a new check runs.
May combine two claims.
Premisecitation§ 1.3.2.4 Osmolarity · p. 10The osmolarity of even a single medium type, such as MEM made in different laboratories, can vary considerably; this can arise due to unwitting use of differently hydrated salt preparations at the same molar concentration.
“The osmolarity of even a single medium type, such as MEM made in different laboratories, can vary considerably; this can arise due to unwitting use of differently hydrated salt preparations at the same molar concentration (Waymouth, 1970).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Waymouth, 1970 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 2.2.1 Cells and tissues · p. 12Other techniques may also be utilized for cell line identity testing, including aldolase gene intron PCR, isoenzyme analysis, and karyology.
“Other techniques may also be utilized, including aldolase gene intron PCR, isoenzyme analysis, and karyology (International Stem Cell Banking Initiative, 2009).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites International Stem Cell Banking Initiative, 2009
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Premisecitation§ 1.6 Microbial and viral contaminations · p. 10Potential sources of viral contamination include the operator, cell culture reagents of animal origin, cells or tissues of human origin (including feeder cells), and even contamination derived from liquid nitrogen storage vessels.
“In cell culture, there are also various potential sources of viral contamination, including the operator, cell culture reagents of animal origin, cells or tissues of human origin (including feeder cells), and even contamination derived from liquid nitrogen storage vessels (Fountain et al., 1997; Grout and Morris, 2009; Morris, 2005).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ 2.2.1 Cells and tissues · p. 12Viral contamination screening may be more difficult to establish due to the high complexity and cost of performing tests for general viral contamination and the potentially large number of viruses involved.
“Viral contamination screening may be more difficult to establish due to the high complexity and cost of performing tests for general viral contamination (e.g., electron microscopy, animal inoculation, and cell culture inoculation) and the potentially large number of viruses involved.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ 1.6 Microbial and viral contaminations · p. 10Visual assessment is not sufficient, and daily medium change with defined serum-free medium can repress contaminations to levels only detectable using a TSB/FTB broth inoculation.
“Note that visual assessment is not sufficient, and daily medium change with defined serum-free medium can repress contaminations to levels only detectable using a TSB/FTB broth inoculation (O'Shea et al., 2020).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites O'Shea et al., 2020 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 2.2.1 Cells and tissues · p. 12Acceptable intervals for periodic testing to confirm the genetic and phenotypic stability of the cell system can be highly case-dependent.
“It is recommended to develop acceptable intervals for periodic testing to confirm the genetic and phenotypic stability of the cell system; these, however, can be highly case-dependent (Blazquez-Prunera et al., 2017; Daily et al., 2017; Meza-Zepeda et al., 2008).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Blazquez-Prunera et al., 2017 source
Checked before — its earlier verdict is held back until a new check runs.
- cites Daily et al., 2017 source
Checked before — its earlier verdict is held back until a new check runs.
- cites Meza-Zepeda et al., 2008
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Premisecitation§ 1.3.1.2 Medium additives · p. 8Animal sera present several limitations, mainly associated with their complexity: lability, viral contamination (potentially with multiple viruses), and batch-to-batch variability.
“Animal sera present several limitations, mainly associated with their complexity: lability, viral contamination (potentially with multiple viruses), and batch-to-batch variability (Brunner et al., 2010; Gstraunthaler, 2003; Nims and Harbell, 2017).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 2.2.1 Cells and tissues · p. 12There are many different methods available to test for contaminations.
“There are many different methods available to test for contaminations (Baumstummler et al., 2010; Coté, 2001).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Baumstummler et al., 2010 source
- cites Coté, 2001
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Premisecitation§ 1.2.2 Stability of in vitro culture · p. 7Genetic variants may exhibit a number of changes including point mutations, small deletions, rearrangements, inversions, gene amplifications, and chromosome loss or aneuploidy, but it is typically difficult to predict their impact on functionality or patient safety in clinical applications.
“Genetic variants may exhibit a number of changes including point mutations, small deletions, rearrangements, inversions, gene amplifications, and chromosome loss or aneuploidy, but it is typically difficult to predict their impact on functionality or patient safety in clinical applications (O'Shea et al., 2020).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites O'Shea et al., 2020 source
May combine two claims.
Premisecitation§ 1.3.2.2 Atmosphere · p. 9High levels of oxygen and carbon dioxide will be toxic, and low levels may inhibit cell growth and/or cause significant changes in gene expression.
“For both gases, high levels will be toxic, and low levels may inhibit cell growth and/or cause significant changes in gene expression (Majmundar et al., 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Majmundar et al., 2010 source
Checked before — its earlier verdict is held back until a new check runs.
May combine two claims.
Premisecitation§ 1.3.2.2 Atmosphere · p. 9Low oxygen levels promote self-renewal of a number of stem cell types, increase efficiency of reprogramming to induce pluripotency, and are important for PSC fate specification.
“In particular, they promote self-renewal of a number of stem cell types, increase efficiency of reprogramming to induce pluripotency (Hawkins et al., 2013), and have been shown to be important for PSC fate specification (Hawkins et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hawkins et al., 2013 source
May combine two claims.
Premisecitation§ 1.6 Microbial and viral contaminations · p. 10Contamination with microorganisms and viruses can result in the catastrophic loss of cultures, and contaminations may potentially spread and infect other cultures, lab personnel and operators in a laboratory.
“Contamination with microorganisms and viruses can result in the catastrophic loss of cultures, and contaminations may potentially spread and infect other cultures, lab personnel and operators in a laboratory (Uphoff et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Uphoff et al., 2010 source
Checked before — its earlier verdict is held back until a new check runs.
May combine two claims.
Premisecitation§ 1.3.2.3 pH · p. 9pH indicators may affect the phenotype and functionality of specific cell types and may interfere with downstream assay readouts; phenol red is known to have some endocrine disrupting effects.
“On the other hand, pH indicators may affect the phenotype and functionality of specific cell types and may interfere with downstream assay readouts, e.g., phenol red is known to have some endocrine disrupting effects (Berthois et al., 1986).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Berthois et al., 1986 source
Not checked in the free run.
May combine two claims.
Premisecitation§ 1.3.2.2 Atmosphere · p. 9Reduced oxygen tension can have a significant impact on cell culture phenotype and is considered beneficial for the culture and differentiation of PSCs.
“Reduced oxygen tension can have a significant impact on cell culture phenotype and is considered beneficial for the culture and differentiation of PSCs (Ivanovic, 2009; Jez et al., 2015; Pamies et al., 2013).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Interpretationreasoning§ 1.3.1.2 Medium additives · p. 8Serum-free preparations reduce the need for serum-based cell culture media and therefore significantly reduce the risk of microbial contamination, improve standardization of cell culture experimental work by decreasing biological variability, and reduce the need for batch pre-use testing.
“Such formulations reduce the need for serum-based cell culture media and therefore significantly reduce the risk of microbial contamination, improve standardization of cell culture experimental work by decreasing biological variability, and reduce the need for batch pre-use testing.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone given§ ii) Quantification and range setting · p. 18For some GAC, no validated assays may exist or they are very challenging to establish, as in the case of some functional assays.
“As already discussed in 2.1, for some GAC, no validated assays may exist or they are very challenging to establish, as in the case of some functional assays.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationreasoning§ 2.3.2.1 Background and examples · p. 17The specific sets of GAC criteria are likely to vary for different cell cultures and may also need to be developed for different applications of those cultures.
“The specific sets of criteria are likely to vary for different cell cultures and may also need to be developed for different applications of those cultures.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ 4.2.1 Physical hazards · p. 28The main physical hazards in the cell and tissue culture laboratory are associated with the use of pressurized gases, for which there are specific government safety regulations.
“In general, the main physical hazards in the cell and tissue culture laboratory are associated with the use of pressurized gases, for which there are specific government safety regulations (e.g., Directive 2014/68/EU (EU, 2014)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EU, 2014
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone given§ 2.2.1 Cells and tissues · p. 14For tissues, the selection of GAC will be constrained by the size of test samples.
“For tissues, the selection of GAC (see 2.3) will be constrained by the size of test samples (although their culture media, storage solutions, or washes may be used for certain testing, such as microbial contamination).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Premisecitation§ 3 Principle 3: Documentation and reporting of the information necessary to track the materials and methods used, to permit the replication of the work, and to enable the target audience to understand and evaluate the work · p. 20Thorough documentation and recording improve the transparency and efficiency of scientific research, can be used to improve reproducibility, and enable work to be repeated.
“Furthermore, thorough documentation and recording improve the transparency and efficiency of scientific research, can be used to improve reproducibility, and enable work to be repeated (Baker, 2016a,b; Munafo et al., 2017).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 2.2.1 Cells and tissues · p. 14Such assays for qualifying new batches of primary cells may include morphology, histochemistry, cell markers, specific tissue function, and cell-cell/matrix interactions.
“Such assays may include morphology, histochemistry, cell markers, specific tissue function, and cell-cell/matrix interactions (Stacey and Hartung, 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stacey and Hartung, 2006 source
May combine two claims.
Premisecitation§ 3.1 Source, origin, and basic description of cultured cells · p. 20There is no universally accepted naming convention for all cell lines, but some fields, such as PSCs, have published standards to systematically create unique cell line identifiers.
“Although there is no universally accepted naming convention for all cell lines, some fields, such as PSCs, have published standards to systematically create unique cell line identifiers (Kurtz et al., 2018; Reid, 2017).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ 2.2.1 Cells and tissues · p. 13Various methods are available for different cell types, and each type of technique measures different aspects of cell physiology, growth, and function.
“Various methods are available for different cell types, and it is important to recognize that each type of technique measures different aspects of cell physiology, growth, and function (for a detailed discussion on viability and functionality tests representing a multi-center consensus, see Stacey et al., 2016a).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stacey et al., 2016a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Premisecitation§ 2.3.4 Matrix · p. 18Biological matrices used to simulate the extracellular matrix of a native tissue are prone to variability and other quality problems, although a number of these are eliminated or reduced by the use of synthetic matrices (such as hydrogels).
“As already discussed (Principles 1 and 2.2), biological matrices used to simulate the extracellular matrix of a native tissue are prone to variability and other quality problems, although a number of these are eliminated or reduced by the use of synthetic matrices (such as hydrogels).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Principles 1 and 2.2
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 5.2 Use of human cells and tissues · p. 32Directive 2004/23/EC covers standards for donation, procurement and testing, processing, preservation, storage, and distribution of human tissues and cells for use in humans.
“Regarding traceability of tissues and cells used as starting materials in a medicinal product for the EU, Directive 2004/23/EC (also known as the European Tissues and Cells Directive) (EU, 2004) covers standards for donation, procurement and testing, processing, preservation, storage, and distribution of human tissues and cells for use in humans 27 .”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites EU, 2004
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim.
Interpretationreasoning§ 2.3.1 Definition and rationale · p. 17The quality of output from each stage of cell culture generation can affect subsequent quality.
“Clearly, the quality of output from each of these stages can affect subsequent quality, such as the thawing of cells (stage 2) for expansion (stage 3).”
Quote in the paperSubstantial claimMay combine two claims.
Premisecitation§ 2.3.2.1 Background and examples · p. 17Such parameters (seeding efficiency, plating efficiency, proliferation rate) may change with increasing population doublings or use of different cell culture conditions.
“Such parameters may change with increasing population doublings (Vracko et al., 1983) or use of different cell culture conditions (Chan et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Vracko et al., 1983 source
- cites Chan et al., 2008
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based).
Interpretationnone given§ 2.3.1 Definition and rationale · p. 16There are too many parameters that would fully define the state of cell cultures.
“The reason is that there are too many parameters that would fully define the state of cell cultures.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ 2.2.5 Laboratory environment · p. 16Class II BSC standards include checking the efficiency of HEPA filters, air flow rate from the cabinet, and operator protection factor for BSC Class II cabinets.
“These standards include checking the efficiency of HEPA filters, air flow rate from the cabinet, and operator protection factor for BSC Class II cabinets.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites EN12469:2000
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites NSF/ANSI 49-2016/BS5726
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 2.2.5 Laboratory environment · p. 16Air quality in cell culture situations is typically established according to ISO 14644-1 and other national standards as applicable for the work.
“Air quality in such situations is typically established according to ISO 14644-1 13 and other national standards as applicable for the work.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites ISO 14644-1
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ 5.2 Use of human cells and tissues · p. 32Products developed based on human cell lines for the manufacture of cell therapies are closely regulated in the EU and US as investigational medical products and are subject to market authorization by the European Medicines Agency or the US FDA.
“Products developed based on human cell lines for the manufacture of cell therapies are closely regulated in the EU and US as investigational medical products and are subject to market authorization by the European Medicines Agency or the US FDA (EC, 2007; EU, 2001b; FDA, 2013, 2015a,b,c), respectively.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites EC, 2007
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites EU, 2001b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites FDA, 2013, 2015a,b,c
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Premisereasoning§ 3 Principle 3: Documentation and reporting of the information necessary to track the materials and methods used, to permit the replication of the work, and to enable the target audience to understand and evaluate the work · p. 20In vitro culture systems have specific challenges: inherent variation of cultured cells, genetic instability, phenotypic drift, ageing, cell senescence due to prolonged passaging, unrecognized viral and/or mycoplasma infections, cross-contamination, or mislabeling of cultures.
“Specific challenges of in vitro culture systems are the inherent variation of the cultured cells, genetic instability, and/or phenotypic drift of the culture, ageing, and cell senescence in culture due to prolonged passaging, unrecognized viral and/or mycoplasma infections, cross-contamination, or mislabeling of cultures (Principle 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Principle 1
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ ii) Quantification and range setting · p. 18Engagement in multi-laboratory coordination studies can contribute to maintaining ongoing improvement in QC, standardization, and compliance with professional standards.
“Engagement in such studies, where relevant, can contribute to maintaining ongoing improvement in QC, standardization, and compliance with professional standards.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ 4.2.3 Biological hazards · p. 29It may not be possible to screen for all potential contaminants for practical reasons of time and costs.
“It may not be possible to screen for all potential contaminants for practical reasons of time and costs”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationreasoning§ i) Selection of appropriate parameters · p. 17Use of parameters based on cell surface markers or mRNA expression do not necessarily correlate directly with culture functionality, but can provide valuable information, given that markers of biological functions may be difficult to standardize and measure reliably.
“Use of parameters based on cell surface markers or mRNA expression do not necessarily correlate directly with culture functionality, but can provide valuable information, given that markers of biological functions may be difficult to standardize and measure reliably.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 5.2 Use of human cells and tissues · p. 32In the US, donor selection criteria are based on those described in Part 21 Code of Federal Regulations 630 and 606.
“In the US, donor selection criteria are based on those described in Part 21 Code of Federal Regulations 630 (FDA, 2019a) and 606 (FDA, 2019b).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites FDA, 2019a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites FDA, 2019b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone given§ 5.3 Use of animal tissues · p. 33Many of the best practices for human cells and tissues described above are also relevant to procurement and use of animal tissues.
“Many of the best practices for human cells and tissues described above are also relevant to procurement and use of animal tissues.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoning§ Laws and regulations · p. 36Through a consensus process, the feedback from stakeholders was incorporated into the GCCP 2.0 manuscript by the Steering Committee.
“Through a consensus process, this feedback was incorporated into the manuscript by the Steering Committee.”
Quote in the paperNot a substantial claim- Rests on an assumption: Acceptance among different scientists in the field is key for an optimal implementation of the guidance document.
Classified as probably not a substantial claim.
Study design and conductreasoning§ Laws and regulations · p. 36A variety of relevant stakeholders, including editors of journals, scientific societies, and regulatory and funding agencies involved in cell culture, were approached and requested to provide feedback on the GCCP 2.0 manuscript.
“In order to promote the large-scale implementation of the principles, a variety of relevant stakeholders - ranging from editors of journals and scientific societies to regulatory and funding agencies involved in cell culture - were approached and requested to provide feedback on the manuscript.”
Quote in the paperSubstantial claim- Rests on an assumption: Acceptance among different scientists in the field is key for an optimal implementation of the guidance document.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ 5.3 Use of animal tissues · p. 33These practices include colony screening to exclude the presence of key pathogens and the use of approved animal husbandry practices.
“These practices include colony screening to exclude the presence of key pathogens and the use of approved animal husbandry practices.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites EU, 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [29]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ 5.3 Use of animal tissues · p. 33Genetic manipulation experiments are regulated in the EU, USA, and in many other countries, where relevant approval must be sought before any work is initiated.
“Genetic manipulation experiments are regulated in the EU (EU, 2001a), USA (FDA, 2015a,b,c), and in many other countries, where relevant approval must be sought before any work is initiated.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites EU, 2001a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites FDA, 2015a,b,c
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitation§ Laws and regulations · p. 36The GCCP 2.0 manuscript was initially developed and approved by the GCCP Steering Committee.
“Thus, the manuscript was initially developed and approved by the GCCP Steering Committee (Pamies et al., 2020).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pamies et al., 2020
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 5.3 Use of animal tissues · p. 33The 3Rs principles were first described by Russell and Burch (1959).
“A central issue for any work that involves tissues harvested from animals is that it is compliant with relevant national legislation as well as the 3Rs principles (replacement, reduction, and refinement) first described by Russell and Burch (1959).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Russell and Burch (1959)
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Classified as probably not a substantial claim.
Interpretationreasoning§ Laws and regulations · p. 36The GCCP 2.0 document provides the necessary information to promote the generation of good-quality reproducible data.
“In conclusion, this document is a comprehensive guidance document that has received broad-ranging input from many fields and provides the necessary information to promote the generation of good-quality reproducible data, facilitate inter-laboratory comparability, and to help overcome possible problems intrinsic to cell culture work.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 5.3 Use of animal tissues · p. 33The manufacture of basement membrane extracts and fetal calf serum is ethically problematic.
“For example, the manufacture of basement membrane extracts and fetal calf serum is ethically problematic (see references in (van der Valk et al., 2018).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites van der Valk et al., 2018
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ 5.3 Use of animal tissues · p. 33These concerns can be addressed by the use of human serum, synthetic alternatives, or serum-free preparations, provided optimal culture conditions can be maintained.
“These concerns can be addressed by the use of human serum, synthetic alternatives, or serum-free preparations, provided optimal culture conditions can be maintained.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ 5.2 Use of human cells and tissues · p. 32Such regulations have significant implications for interactions between research groups where personal data include exchange of genetic sequences.
“Such regulations have significant implications for interactions between research groups where personal data include exchange of genetic sequences.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Interpretationreasoning§ Laws and regulations · p. 36The GCCP 2.0 document provides the necessary information to help overcome possible problems intrinsic to cell culture work.
“In conclusion, this document is a comprehensive guidance document that has received broad-ranging input from many fields and provides the necessary information to promote the generation of good-quality reproducible data, facilitate inter-laboratory comparability, and to help overcome possible problems intrinsic to cell culture work.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
Premisecitation§ 6.3 Advanced and special culture procedures · p. 34Comprehensive training for research groups within a multinational project consortium is of significant value to increase robustness and reproducibility of methods and to strictly adhere to agreed protocols or SOPs to facilitate/enable comparisons of research findings within the consortium.
“Specifically, comprehensive training for research groups within a multinational project consortium is of significant value to increase robustness and reproducibility of methods and to strictly adhere to agreed protocols or SOPs to facilitate/enable comparisons of research findings within the consortium (Pamies et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pamies et al., 2017 source
Checked before — its earlier verdict is held back until a new check runs.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationreasoning§ 4.3.2 Transport · p. 30These classifications will dictate the specific requirements for shipment.
“These classifications will dictate the specific requirements for shipment.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Interpretationreasoning§ Laws and regulations · p. 36The GCCP 2.0 document provides the necessary information to facilitate inter-laboratory comparability.
“In conclusion, this document is a comprehensive guidance document that has received broad-ranging input from many fields and provides the necessary information to promote the generation of good-quality reproducible data, facilitate inter-laboratory comparability, and to help overcome possible problems intrinsic to cell culture work.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ 5.2 Use of human cells and tissues · p. 32Data held on donors of tissue used to generate cell lines may also be subject to regulations, such as those existing in the US and EU, superseded by the General Data Protection Regulation (EU) 2016/679 in 2016.
“Data held on donors of tissue used to generate cell lines may also be subject to regulations, such as those existing in the US (FDA, 2001, 2010) and EU (EU Directive on Data Protection (EU, 1995)) superseded by the General Data Protection Regulation (EU) 2016/679 (GDPR) in 2016.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites FDA, 2001, 2010
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites EU, 1995
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites EU, 2016/679
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ 5.2 Use of human cells and tissues · p. 32European legislation for the import and export of tissues for clinical use regulates cell and tissue procurement, processing, storage, and testing.
“For a specific example, European legislation for the import and export of tissues for clinical use (EU, 2012, 2006a,b,c) regulates cell and tissue procurement, processing, storage, and testing.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites EU, 2012
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites EU, 2006a,b,c
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
Premisecitation§ 6.1 Laboratory training · p. 34Understanding of the nature and purpose of SOPs facilitates the adequate performance of experiments to obtain good-quality data.
“Moreover, understanding of the nature and purpose of SOPs facilitates the adequate performance of experiments to obtain good-quality data.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Freshney, 2016
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
The paper relies on this without support.
Cell models have advanced dramatically to more complex culture systems.
“The update in the guidance was essential as cell models have advanced dramatically to more complex culture systems and need more comprehensive quality management to ensure reproducibility and high-quality scientific data.”
The paper relies on this without support.
More comprehensive quality management is needed to ensure reproducibility and high-quality scientific data.
“The update in the guidance was essential as cell models have advanced dramatically to more complex culture systems and need more comprehensive quality management to ensure reproducibility and high-quality scientific data.”
The paper relies on this without support.
Reproducibility of in vitro (cell-based) work is important and desirable.
“This guidance document attempts a current examination of the requirements to assure the reproducibility of in vitro (cell-based) work.”
The paper relies on this without support.
Applying the factors described in GCCP will promote reproducibility in scientific research and facilitate the development of novel cell-based technologies, methods, and products.
“These factors are key to promoting reproducibility in scientific research and facilitating the development of novel cell-based technologies, methods, and products for public and commercial purposes.”
The paper relies on this without support.
Stable interventions such as gene-editing and vector transformation can generate modified cells with different integration sites or other features that may affect their expression and utility.
“Gene-editing, vector transformation, and other stable interventions can generate large numbers of modified cells with different integration sites or other features that may affect their expression and the utility of the different clones for their intended use.”
The paper relies on this without support.
Cell fusion and creation of cell hybrids can generate complex and diverse combinations of cellular composition that bring together functional and possibly competing structures, organelles, biochemistry, and genetic mechanisms.
“Cell fusion and the creation of cell hybrids can generate complex and diverse combinations of cellular composition from different cell types, and even different species, that will potentially bring together functional and possibly competing structures, organelles, biochemistry, and genetic mechanisms in the same derivative cell.”
The paper relies on this without support.
It has been difficult to harmonize cell naming across the field of cell culture users.
“However, it has been difficult to harmonize cell naming across the field of cell culture users.”
The paper relies on this without support.
Phenotypic heterogeneity in cell cultures may occur between different passages.
“As already discussed, phenotypic heterogeneity in cell cultures may occur between different passages.”
The paper relies on this without support.
Undetected contamination with slow-growing microorganisms or antibiotic-resistant microorganisms can have a significant impact on the quality and/or validity of data obtained from in vitro systems.
“Undetected contamination with slow-growing microorganisms or with microorganisms that are resistant to antibiotics can have a significant impact on the quality and/or validity of data obtained from in vitro systems”
The paper relies on this without support.
Routine use of antibiotics in cell and tissue culture can result in widespread suppressed contamination of cell stocks, which may only become evident when antibiotics are removed.
“When the use of antibiotics becomes routine in the cell and tissue culture laboratory, it can result in widespread suppressed contamination of cell stocks, which may only become evident when antibiotics are removed.”
The paper relies on this without support.
Mycoplasma contamination may remain undetectable without a specific test.
“However, contamination with mycoplasma may remain undetectable without a specific test.”
The paper relies on this without support.
The type of matrix can significantly influence the functionality of a particular cell type and differentiation of progenitor and stem cell cultures.
“The type of matrix can significantly influence the functionality of a particular cell type and differentiation of progenitor and stem cell cultures”
The paper relies on this without support.
The optimal physiological pH for mammalian cell cultures is considered to be pH 7.3 ± 0.1 and pH 6.0 for insect cells.
“The optimal physiological pH for mammalian cell cultures is considered to be pH 7.3 ± 0.1 and pH 6.0 for insect cells.”
The paper relies on this without support.
Cell culture media have typically been designed to mimic the osmolarity in serum (290 mOsm) and are usually 290±30 mOsm.
“Cell culture media have typically been designed to mimic the osmolarity in serum (290 mOsm) and are usually 290±30 mOsm.”
The paper relies on this without support.
STR methods are available for some animal species.
“STR methods are also available for some animal species.”
The paper relies on this without support.
The available techniques for genomic integrity testing differ in methodological approach, size and comprehensiveness of the genetic changes they can detect, and sensitivity for low-level variants.
“The selection of a single technique is not straightforward because the available techniques differ in methodological approach, size and comprehensiveness of the genetic changes they can detect, and sensitivity for low-level variants.”
The paper relies on this without support.
Bacteria, fungi, and mycoplasma can be detected from culture cells and supernatants or tissue media by established Pharmacopoeia methods based on inoculation of microbiological culture media, which may need to be specialized for certain organisms like mycoplasma.
“Bacteria, fungi, and mycoplasma can be detected from culture cells and supernatants or tissue media by established Pharmacopoeia methods based on inoculation of microbiological culture media, which may need to be specialized for certain organisms like mycoplasma.”
The paper relies on this without support.
Molecular methods, including qPCR, can provide sensitive and rapid methods for detection of all mycoplasma species and all bacteria by detection of conserved sequences in ribosomal RNA.
“Molecular methods, including qPCR, can provide sensitive and rapid methods for detection of all mycoplasma species and all bacteria by detection of conserved sequences in ribosomal RNA.”
The paper relies on this without support.
Screening for serious human bloodborne pathogens may be available for tissue donors, and regular microscopic observation may reveal viral cytopathic effects.
“However, screening for serious human bloodborne pathogens may be available for tissue donors, and regular microscopic observation may reveal viral cytopathic effects.”
The paper relies on this without support.
Molecular screening by multi-virus PCR panels and next-generation sequencing methods could provide useful tools covering significant numbers of viruses, but also require careful validation and control if used as primary safety tests.
“Molecular screening by multi-virus PCR panels and next-generation sequencing methods could provide useful tools covering significant numbers of viruses (and are easily accessible via commercial service providers), but also require careful validation and control if used as primary safety tests.”
The paper relies on this without support.
Working in a BSC Class II with poor aseptic technique will decrease the cabinet's protective effect for work and worker.
“Working in a BSC Class II with poor aseptic technique will decrease the cabinet's protective effect for work and worker, and examples of precautions to ensure the correct and safe use of a Class II BSC are given in Appendix 6 1 .”
The paper relies on this without support.
Cell culture contaminants may include reagent impurities, plasticizers, volatiles, detergents, and micro-organisms.
“Cell culture contaminants may include reagent impurities (in media, sera, water, and endotoxins), plasticizers (in plasticware), volatiles (e.g., formaldehyde from paper towels, organic volatiles in paints), detergents, and micro-organisms.”
The paper relies on this without support.
Some laboratories may require documented review and authorization of research data, including personal laboratory books, for scientific good practice and protection of intellectual property.
“For the purposes of scientific good practice and protection of intellectual property, some laboratories may require documented review and authorization of research data, including personal laboratory books.”
The paper relies on this without support.
These data transfer issues are of special concern where data are exchanged between countries where different formats (for example, decimal separators) may be in use.
“These issues are of special concern where data are exchanged between countries where different formats (for example, decimal separators) may be in use.”
The paper relies on this without support.
Certain cell systems, such as differentiated PSC, may develop to the desired state through a characteristic differentiation trajectory.
“In addition, certain cell systems, such as differentiated PSC, may develop to the desired state through a characteristic differentiation trajectory.”
The paper relies on this without support.
In parallel with regulatory demands, academic research is increasingly committed to rules that ensure reproducibility of research data.
“In parallel with regulatory demands, academic research is increasingly committed to rules that ensure reproducibility of research data.”
The paper relies on this without support.
The differentiation of cells may be formally included as part of the intended final use, such as an assay or product manufacture procedure, and may only be considered at that stage.
“The differentiation of cells may be formally included as part of the intended final use, such as an assay or product manufacture procedure, and may only be considered at that stage.”
The paper relies on this without support.
An experienced operator may intuitively assess cell culture status based on a number of key parameters, such as morphology, size, confluency, general appearance, and other parameters like passage number, discarding cultures they regard as unsuitable.
“An experienced operator may intuitively assess cell culture status based on a number of key parameters, such as morphology, size, confluency, general appearance, and other parameters like passage number, discarding cultures they regard as unsuitable.”
The paper relies on this without support.
Examples of fundamental types of GAC are the seeding efficiency, plating efficiency, and proliferation rate of the cell line in use.
“Examples of fundamental types of GAC are the seeding efficiency, plating efficiency, and proliferation rate of the cell line in use.”
The paper relies on this without support.
Hardly any cell culture is truly 2-dimensional and also so-called monocultures contain a variety of different cell states/shapes/sizes/functionalities.
“However, it is becoming clear that hardly any cell culture is truly 2-dimensional and that also so-called monocultures contain a variety of different cell states/shapes/sizes/functionalities.”
The paper relies on this without support.
The issue of complexity is even more pronounced for 3-dimensional culture systems involving combinations of factors, including new culture environments and conditions, phenotypic development, migration, matrix production, etc.
“The issue of complexity is even more pronounced for 3-dimensional culture systems involving combinations of factors, including new culture environments and conditions, phenotypic development, migration, matrix production, etc.”
The paper relies on this without support.
There are few instances where GAC have been documented for the surface matrices, primarily due to technical difficulties of defining and quantifying the state of the model extracellular matrix (ECM).
“Nevertheless, there are few instances where GAC have been documented for the surface matrices, primarily due to technical difficulties of defining and quantifying the state of the model extracellular matrix (ECM) (composition, structural consistency, porosity, molecular integrity, etc.).”
The paper relies on this without support.
Purity of the original preparations is likely to be a key GCCP acceptance criterion that may include expansion of unwanted cells.
“In addition, the purity of the original preparations is likely to be a key GCCP acceptance criterion (as discussed above - see Section 2.3.1) that may include expansion of unwanted cells (e.g., fibroblast expansion from tissue explants, side-populations of differentiating PSCs, composition of self-organizing organoid systems, cell ratios in co-cultures).”
The paper relies on this without support.
Numerous examples (notably hybridomas) are now treated for QC purposes as if they were 'standard' continuous cell lines, but some may have been altered in a way that requires new and bespoke GAC.
“Numerous examples (notably hybridomas) are now treated for QC purposes as if they were 'standard' continuous cell lines, but some may have been altered in a way that requires new and bespoke GAC (see also Appendix 2 and 3 1 ).”
The paper relies on this without support.
An often-underappreciated problem experienced in cell culture quality is the effect of analytical methods on cells.
“An often-underappreciated problem experienced in cell culture quality is the effect of analytical methods on cells.”
The paper relies on this without support.
The effect of analytical methods on cells can result in drastically altered cultures and also in variation of test results due to changes in the cell culture response.
“This can result in drastically altered cultures and also in variation of test results due to changes in the cell culture response.”
The paper relies on this without support.
Loading cells with fluorescent indicators may alter calcium buffering in cells, contribute to phototoxicity not seen otherwise, or have other side-effects that require control.
“Another important group of examples refers to the loading of cells with fluorescent indicators. They may alter calcium buffering in cells, contribute to phototoxicity not seen otherwise, or have other side-effects that require control.”
The paper relies on this without support.
All live-cell imaging methods may involve stimuli with consequences that cannot always be anticipated and that may require control of the cell populations under defined assay conditions.
“Basically, all live-cell imaging methods (even though they are considered to be non-invasive) may involve stimuli with consequences that cannot always be anticipated and that may require control of the cell populations under defined assay conditions.”
The paper relies on this without support.
Methods involving transient transfections of reporters used to establish analytical endpoints are known to potentially have significant effects on cell functions and viability.
“In particular, methods involving transient transfections (e.g., electroporation, lipofection, calcium phosphate precipitation) of reporters used to establish analytical endpoints are known to potentially have significant effects on cell functions and viability.”
The paper relies on this without support.
Such effects may show large variations between experiments.
“Moreover, such effects may show large variations between experiments.”
The paper relies on this without support.
Variation, drift, and uncertainty in non-mammalian cell systems are unlikely to be less important than for mammalian cells and will require special scientific evaluation to ensure suitable GAC are implemented.
“It is particularly important to note that the variation, drift, and uncertainty in these systems are unlikely to be less important than for mammalian cells and will require special scientific evaluation to ensure that suitable GAC are implemented beyond those referred to in GCCP 2.0.”
The paper relies on this without support.
It is increasingly common to have diverse experimental conditions in which cells are exposed to light, modified atmospheric or other physical conditions that may alter the performance of the cultures.
“It is also increasingly common to have diverse experimental conditions in which cells are exposed to light, modified atmospheric or other physical conditions that may alter the performance of the cultures and, therefore, need to form part of the GAC considerations to assure they are suitable for the intended analytical platform.”
The paper relies on this without support.
Only measurement of GAC can give an indication whether the cells retain the required range of properties measured during characterization in more standard cell preparation culture systems.
“It may be assumed that such platforms do not affect the cells, but only the measurement of GAC can give an indication whether the cells retain the required range of properties measured during characterization in more standard cell preparation culture systems.”
The paper relies on this without support.
Inadvertent switching of cells thawed from cryovials and vial mislabeling are probably two of the most common causes of cell line cross-contamination.
“Note that inadvertent switching of cells thawed from cryovials and vial mislabeling are probably two of the most common causes of cell line cross-contamination.”
The paper relies on this without support.
Composition of culture media is one of the most influential factors on cell performance.
“Composition of culture media is one of the most influential factors on cell performance.”
The paper relies on this without support.
Use of different substrates to grow cells can have significant impact on cell growth and differentiation.
“Use of different substrates to grow cells can have significant impact on cell growth and differentiation.”
The paper relies on this without support.
A variety of equipment used for the manipulation, maintenance, and storage of cell cultures can impact on the viability, sterility, and performance of cell cultures.
“A variety of equipment used for the manipulation, maintenance, and storage of cell cultures can impact on the viability, sterility, and performance of cell cultures”
The paper relies on this without support.
Women of childbearing age may be at greater risk from the effects of certain chemicals, such as teratogens or biological agents.
“women of childbearing age may be at greater risk from the effects of certain chemicals, such as teratogens or biological agents.”
The paper relies on this without support.
Some chemicals have ill-defined or unknown biological effects.
“some chemicals have ill-defined or unknown biological effects”
The paper relies on this without support.
Handling of liquid nitrogen carries the hazards of cold burns and asphyxiation due to rapid expansion of gaseous nitrogen.
“Handling of liquid nitrogen carries the hazards of cold burns (frostbite) and asphyxiation due to rapid expansion of gaseous nitrogen”
The paper relies on this without support.
The cell and tissue culture laboratory does not pose any specific physical hazards.
“The cell and tissue culture laboratory does not pose any specific physical hazards.”
The paper relies on this without support.
PSC and microphysiological/3D systems are not typically associated with physical hazards different from other cell cultures.
“PSC and microphysiological/3D systems are not typically associated with physical hazards different from other cell cultures.”
The paper relies on this without support.
Incorrect use of devices, particularly those using extreme heat, pressurized steam or gases, irradiation, and mechanically hazardous components, is a major source of hazard.
“incorrect use of devices, and particularly those using extreme heat (e.g., autoclaves, incinerators), pressurized steam or gases, irradiation, and mechanically hazardous components (e.g., centrifuges, sharps such as needles, razor blades, potentially explosive components) is a major source of hazard”
The paper relies on this without support.
Potential biological hazards originate from cultured cells, culture media supplements, and culture techniques and experimental protocols applied.
“Potential biological hazards originate from (1) the cultured cells, (2) the culture media supplements, and (3) the culture techniques and experimental protocols applied”
The paper relies on this without support.
Cells may be inadvertently or deliberately contaminated with pathogens after donation.
“There is also the possibility that cells may be inadvertently or deliberately contaminated with pathogens after donation.”
The paper relies on this without support.
Viral contamination of cell cultures may be without cytopathic effect or latent and hard to detect.
“Viral contamination needs particular attention because infection may be without cytopathic effect for the cell culture or may be latent (e.g., herpes virus, EBV) and hard to detect.”
The paper relies on this without support.
Feeder cell cultures are a potential source of contamination.
“Such cell cultures are a potential source of contamination”
The paper relies on this without support.
The biological risk of infected cell cultures depends on the hazard category of the potential infecting pathogens.
“The biological risk of infected cell cultures depends on the hazard category of the potential infecting pathogens.”
The paper relies on this without support.
The hazard potential of infectious agents determines the degree of containment and biosafety level.
“In general, the hazard potential of infectious agents determines the degree of containment and biosafety level, respectively.”
The paper relies on this without support.
The level of risk from chemicals depends on the formulation of the reagent, the quantities being used, the techniques being employed, and the type of personnel using them.
“The level of risk, for example, will depend on the formulation of the reagent, the quantities being used, the techniques being employed, the type of personnel using them, and the like.”
The paper relies on this without support.
Storage of bulk hazardous material and its handling can represent a significant potential risk, particularly if blinded.
“Although the concentrations used in the final test solutions may be very low, the storage of the bulk material and its handling can represent a significant potential risk, particularly if blinded.”
The paper relies on this without support.
Donor-screening procedures such as virological screening for key pathogens and lifestyle questionnaires can be useful in risk assessment.
“donor-screening procedures such as virological screening for key pathogens and lifestyle questionnaires can be useful in risk assessment.”
The paper relies on this without support.
There may be theoretical risks for laboratory workers becoming infected and transmitting disease outside the laboratory or recombinant organisms, pathogens, or hazardous chemicals escaping the laboratory or being improperly disposed of.
“Furthermore, there may be theoretical risks for laboratory workers becoming infected and transmitting disease outside the laboratory or recombinant organisms, pathogens, or hazardous chemicals escaping the laboratory or being improperly disposed of.”
The paper relies on this without support.
Horizontal laminar flow cabinets are designed to protect only the work area, and their air flow is directed toward the worker, which would expose the worker to contaminants in the cell culture.
“Horizontal laminar flow cabinets may be used for non-hazardous media preparation, but should never be used when handling cells, as such cabinets are designed to protect only the work area, and the air flow is directed toward the worker and would expose them to any contaminants in the cell culture (see Principle 2, Section 2.2).”
The paper relies on this without support.
Pathogens or GMOs may present a risk to the environment where they are able to survive.
“Pathogens or GMOs may present a risk to the environment where they are able to survive.”
The paper relies on this without support.
Such risks are increased in workplaces with poor sterilization and waste disposal practices, leading to contamination of water, air, or soil, or escape from containment.
“Such risks are increased in workplaces with poor sterilization and waste disposal practices, leading to contamination of water, air, or soil, or escape from containment.”
The paper relies on this without support.
The environment can also be contaminated by release of biological material resulting from accidents, including transport accidents.
“The environment can also be contaminated by release of biological material resulting from accidents, including transport accidents, and systems should be put in place either to prevent or minimize the potential for such events.”
The paper relies on this without support.
Animal cells are not capable of independent growth in the environment.
“Since animal cells are not capable of independent growth in the environment, there are no special concerns for cell and tissue culture systems with respect to environmental release.”
The paper relies on this without support.
There are concerns about germline transmission of genetic alterations for patients in clinical trials.
“However, there are concerns about germline transmission of genetic alterations for patients in clinical trials, and new technologies such as stem cell research techniques and gene editing will need to be considered carefully 19 .”
The paper relies on this without support.
Risks to the environment are generally due to poor waste disposal, leading to contamination of water, air, or soil, or the escape from containment of hazardous materials.
“Risks to the environment are generally due to poor waste disposal, leading to contamination of water, air, or soil, or the escape from containment of hazardous materials.”
The paper relies on this without support.
IATA guidelines are stringent and recognized internationally.
“Wherever appropriate, the IATA guidelines 23 should be followed, as they are stringent and recognized internationally.”
The paper relies on this without support.
For cell and tissue culture, it is usually a legal requirement to ensure accountability, health and safety, and ethical practices, regardless of cell type used.
“For cell and tissue culture, it is usually a legal requirement to ensure accountability, health and safety, and ethical practices, regardless of cell type used.”
The paper relies on this without support.
While there are no international laws governing cell and tissue culture procedures, national and international regulations and laws cover the procurement, use, and storage of cells and tissues, their genetic manipulation, and other safety issues.
“While there are no international laws governing cell and tissue culture procedures, national and international regulations and laws cover the procurement, use, and storage of cells and tissues, their genetic manipulation, and other safety issues.”
The paper relies on this without support.
Confidentiality with respect to the provision and use of human tissue is governed by both national and international laws and professional guidelines.
“Confidentiality with respect to the provision and use of human tissue is governed by both national and international laws and professional guidelines.”
The paper relies on this without support.
Most countries require that informed consent be sought from the donor or donor's family (or other authorized persons) when obtaining cells or tissues from human donors.
“In addition, most countries require that informed consent be sought from the donor or donor's family (or other authorized persons) when obtaining cells or tissues from human donors, and thus this should be considered an essential first step in acquiring such materials.”
The paper relies on this without support.
Personnel at hospitals and human tissue banks are knowledgeable about the relevant regulations and are thus best equipped to advise on the complex issues involved with procurement and transportation.
“Personnel at hospitals and human tissue banks are knowledgeable about the relevant regulations and are thus best equipped to advise on the complex issues (e.g., ethics, consent, safety, and logistics) involved with procurement and transportation.”
The paper relies on this without support.
Additional controls on donor information may also apply in some countries.
“Additional controls on donor information may also apply in some countries.”
The paper relies on this without support.
Cell line ownership may mean that there are restrictions on their use even for research purposes.
“Cell line ownership may mean that there are restrictions on their use even for research purposes.”
The paper relies on this without support.
Ownership and patents can be complicated, as several parties may be involved in the negotiation of their use.
“Ownership and patents can be complicated, as several parties may be involved in the negotiation of their use.”
The paper relies on this without support.
For human cell lines, parties involved in negotiation of use could include hospital authority and clinicians, scientists, institution, sponsors, and those who developed enabling technology.
“For human cell lines, these parties could include: the hospital authority and clinicians where the original tissue sample was taken, the scientists engaged in deriving and researching the cell line, the institution that hosted the research, sponsors (such as funding bodies or collaborating commercial companies), and those who developed enabling technology, such as cell reprogramming.”
The paper relies on this without support.
Depending on the nature of consent, the tissue donor may also need to be consulted.
“Depending on the nature of consent, the tissue donor may also need to be consulted.”
The paper relies on this without support.
Given heightened ethical concerns associated with use of human embryos for research, including generation of hESCs, these materials may be prohibited or regulated under strict legislation.
“Given the heightened ethical concerns associated with the use of human embryos for research, including the generation of hESCs, these materials may be prohibited or regulated under strict legislation.”
The paper relies on this without support.
Consent may need to be specific for hESCs and include consent to carry out genetic testing.
“It is also important to note that consent may need to be specific for hESCs and include consent to carry out genetic testing.”
The paper relies on this without support.
Acceptance among different scientists in the field is key for an optimal implementation of the guidance document.
“Acceptance among different scientists in the field is key for an optimal implementation of the guidance document.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Commercially available cells are typically standardized and pre-characterized, while in-house produced cells must follow Good Manufacturing Practices (GMP) and established standards, such as those outlined by the International Society for Stem Cell Research (ISSCR).
“Commercially available cells are typically standardized and pre-characterized, while in-house produced cells must follow Good Manufacturing Practices (GMP) and established standards, such as those outlined by the International Society for Stem Cell Research (ISSCR) (Coecke et al., 2005; Pamies et al., 2022; Ludwig et al., 2023).”
From Considering future qualification for regulatory science in the early development of microphysiological systems: a case study of microthrombosis in a Vessel-on-Chip (2024) · cites this paper as Pamies et al., 2022
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredGood Cell Culture Practices were developed by the research community to face challenges of advanced cellular models, including stem cells and organoids, MicroPhysiological Systems and Organ-on-Chip (Pamies et al. 2022; Pistollato et al. 2022; Pamies et al. 2018; Pamies et al. 2024).
“Complementarily, Good Cell Culture Practices (Pamies et al. 2022; Pistollato et al. 2022) were also developed by the research community to face challenges of advanced cellular models, including stem cells and organoids (Pamies et al. 2018), MicroPhysiological Systems and Organ-on-Chip (Pamies et al. 2024).”
From Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology (2025) · cites this paper as Pamies et al. 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
A 2007 regulation is listed under a 2001 reference label
MinorThe reference labelled "EU (2001b)" describes a regulation dated 13 November 2007. The same regulation is separately listed as "EC (2007)."
“EU (2001b). Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007”
“EC (2007). Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007”
Cites
The FAIR Guiding Principles for scientific data management and stewardship
Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423 · see citing works
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876 · see citing works
The Principles of Humane Experimental Technique
(1960) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1960.tb73127.x · Cited by 5,002 · see citing works
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · see citing works
1,500 scientists lift the lid on reproducibility
Baker, M. (2016) · Nature · doi:10.1038/533452a · Cited by 4,209 · see citing works
A manifesto for reproducible science
Munafò, M. R., Nosek, B. A., Bishop, D. V. M., Button, K. S., Chambers, C. D., Percie du Sert, N., Simonsohn, U., Wagenmakers, E.-J., Ware, J. J., & Ioannidis, J. P. A. (2017) · Nature Human Behaviour · doi:10.1038/s41562-016-0021 · Cited by 3,397 · see citing works
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380 · see citing works
Modeling physiological events in 2D vs. 3D cell culture
Duval, K., Grover, H., Han, L.-H., Mou, Y., Pegoraro, A. F., Fredberg, J., & Chen, Z. (2017) · Physiology · doi:10.1152/physiol.00036.2016 · Cited by 1,849 · cited 1× · see citing works
“…such as the deposition of extracellular matrix, secretion of growth factors, altered cell proliferation, morphological development, lineage differentiation, changes in gene expression levels (Mabry et al., 2016), rate of cell death (Bonnier et al., 2015), or cell migration (Duval et al., 2017).”
BackgroundBerthois, Y., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2496 · Cited by 1,307 · see citing works
Genetic and transcriptional evolution alters cancer cell line drug response
Ben-David, U., Siranosian, B., Ha, G., Tang, H., Oren, Y., Hinohara, K., Strathdee, C. A., Dempster, J., Lyons, N. J., Burns, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0409-3 · Cited by 931 · see citing works
The Cellosaurus, a Cell-Line Knowledge Resource
Bairoch, A. (2018) · Journal of Biomolecular Techniques JBT · doi:10.7171/jbt.18-2902-002 · Cited by 807 · see citing works
Hayflick, his limit, and cellular ageing
Shay, J. W., & Wright, W. E. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036093 · Cited by 764 · see citing works
Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications
Freshney, R. I. (2010) · Cited by 702 · see citing works
Initiative, T. I. S. C. (2011) · Nature Biotechnology · doi:10.1038/nbt.2051 · Cited by 570 · see citing works
Guidelines for the use of cell lines in biomedical research
Geraghty, R. J., Capes‐Davis, A., Davis, J. M., Downward, J., Freshney, R. I., Knežević, I., Lovell-Badge, R. H., Masters, J. R., Meredith, J., Stacey, G. N., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.166 · Cited by 526 · see citing works
Check your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520 · cited 1× · see citing works
“Where such methods are not useful, a selection of other appropriate phenotypic, genotypic or functional markers should be used, e.g., for the use of flow cytometry or immunofluorescence (Capes-Davis et al., 2013).”
MethodHepatitis B transmission from contaminated cryopreservation tank
Tedder, R. S., Zuckerman, M. A., Brink, N. S., Goldstone, A. H., Fielding, A. K., Blair, S., Patterson, K. G., Hawkins, A. E., Gormon, A. M., Heptonstall, J., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91207-x · Cited by 459 · see citing works
The Causes and Consequences of Polyploidy in Normal Development and Cancer
Davoli, T., & de Lange, T. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154234 · Cited by 432 · see citing works
Direct lineage reprogramming: strategies, mechanisms, and applications.
Xu, J., Du, Y.-Y., & Deng, H. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.01.013 · Cited by 409 · see citing works
Serum-free cell culture: the serum-free media interactive online database
Brunner, D. (2010) · ALTEX · doi:10.14573/altex.2010.1.53 · Cited by 386 · see citing works
Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Schechtman, L., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300313 · Cited by 371 · see citing works
Hypoxia or in situ normoxia: The stem cell paradigm
Ivanovic, Z. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21690 · Cited by 346 · see citing works
Biological implications of cell fusion
Ogle, B. M., Cascalho, M., & Platt, J. L. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1678 · Cited by 343 · see citing works
Drexler, H. G., & Uphoff, C. C. (2002) · Cytotechnology · doi:10.1023/a:1022913015916 · Cited by 340 · see citing works
Multi-omic measurements of heterogeneity in HeLa cells across laboratories
Liu, Y., Mi, Y., Mueller, T., Kreibich, S., Williams, E. G., Van Drogen, A., Borel, C., Frank, M., Germain, P.-L., Bludau, I., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0037-y · Cited by 338 · see citing works
Human tissues in a dish: The research and ethical implications of organoid technology
Bredenoord, A. L., Clevers, H., & Knoblich, J. A. (2017) · Science · doi:10.1126/science.aaf9414 · Cited by 334 · see citing works
Keeley, T. P., & Mann, G. E. (2019) · Physiological Reviews · doi:10.1152/physrev.00041.2017 · Cited by 329 · see citing works
Cross-contamination of cells in culture
Nelson-Rees, W. A., Daniels, D. W., & Flandermeyer, R. R. (1981) · Science · doi:10.1126/science.6451928 · Cited by 329 · see citing works
Process engineering of human pluripotent stem cells for clinical application
Serra, M., Brito, C., Correia, C., & Alves, P. M. (2012) · Trends in biotechnology · doi:10.1016/j.tibtech.2012.03.003 · Cited by 303 · see citing works
Fetal Bovine Serum (FBS): past ‐ present ‐ future
van der Valk, J. (2018) · ALTEX · doi:10.14573/altex.1705101 · Cited by 299 · see citing works
Marx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295 · see citing works
Cell viability assessment using the Alamar blue assay: A comparison of 2D and 3D cell culture models
Bonnier, F., Keating, M. E., Wróbel, T. P., Majzner, K., Baranska, M., Garcia-Munoz, A., Blanco, A., & Byrne, H. J. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.09.014 · Cited by 276 · see citing works
Marx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 271 · see citing works
A Simple Hanging Drop Cell Culture Protocol for Generation of 3D Spheroids
Foty, R. (2011) · Journal of Visualized Experiments · doi:10.3791/2720 · Cited by 263 · see citing works
Awan, M., Buriak, I. A., Fleck, R. A., Fuller, B. J., Goltsev, А., Kerby, J., Lowdell, M. W., Měřička, P., Petrenko, O., Petrenko, Y., et al. (2020) · Regenerative Medicine · doi:10.2217/rme-2019-0145 · Cited by 255 · see citing works
Villa-Diaz, L. G., Ross, A. M., Lahann, J., & Krebsbach, P. H. (2012) · Stem Cells · doi:10.1002/stem.1260 · Cited by 251 · see citing works
A review of cellularization strategies for tissue engineering of whole organs
Scarritt, M. E. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00043 · Cited by 234 · see citing works
Genetic basis of cell–cell fusion mechanisms
Aguilar, P. S., Baylies, M. K., Fleißner, A., Helming, L., Inoue, N., Podbilewicz, B., Wang, H., & Wong, M. H. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.01.011 · Cited by 232 · see citing works
The hallmarks of cell-cell fusion
Hernández, J. M., & Podbilewicz, B. (2017) · Development · doi:10.1242/dev.155523 · Cited by 205 · see citing works
Match criteria for human cell line authentication: Where do we draw the line?
Capes‐Davis, A., Reid, Y. A., Kline, M. C., Storts, D. R., Strauss, E., Dirks, W. G., Drexler, H. G., MacLeod, R. A. F., Sykes, G., Kohara, A., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27931 · Cited by 189 · cited 1× · see citing works
“Recent developments in automation allow accommodation of complex culture systems in automated screening applications (Carragher et al., 2018).”
BackgroundMeza‐Zepeda, L. A., Noer, A., Dahl, J. A., Micci, F., Myklebost, O., & Collas, P. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00146.x · Cited by 169 · see citing works
Gene name errors are widespread in the scientific literature
Ziemann, M., Eren, Y., & El-Osta, A. (2016) · Genome Biology · doi:10.1186/s13059-016-1044-7 · Cited by 168 · see citing works
Volpato, V., Smith, J., Sandor, C., Ried, J. S., Baud, A., Handel, A., Newey, S. E., Wessely, F., Attar, M., Whiteley, E., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.08.013 · Cited by 165 · see citing works
Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research Purposes
Initiative, T. I. S. C. B. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9085-x · Cited by 162 · see citing works
Guidance Document on Good In Vitro Method Practices (GIVIMP)
OECD (2018) · OECD Series on Testing and Assessment · doi:10.1787/9789264304796-en · Cited by 161 · see citing works
Changing medium and passaging cell lines
Masters, J. R., & Stacey, G. N. (2007) · Nature Protocols · doi:10.1038/nprot.2007.319 · Cited by 160 · see citing works
Fountain, D., Ralston, M., Higgins, N., Gorlin, J., Uhl, L., Wheeler, C., Antin, J., Churchill, W., & Benjamin, R. (1997) · Transfusion · doi:10.1046/j.1537-2995.1997.37697335152.x · Cited by 155 · see citing works
Oxygenation in Cell Culture: Critical Parameters for Reproducibility Are Routinely Not Reported
Al-Ani, A., Toms, D., Kondro, D., Thundathil, J., Yu, Y., & Ungrin, M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204269 · Cited by 152 · see citing works
A versatile prion replication assay in organotypic brain slices
Falsig, J., Julius, C., Margalith, I., Schwarz, P., Heppner, F. L., & Aguzzi, A. (2007) · Nature Neuroscience · doi:10.1038/nn2028 · Cited by 145 · see citing works
Andrews, P. W., Baker, D., Benvinisty, N., Miranda, B., Bruce, K., stle, O. B. X. F., Choi, M.-J., Choi, Y.-M., Crook, J. M., Sousa, P. A. D., et al. (2015) · Regenerative Medicine · doi:10.2217/rme.14.93 · Cited by 145 · see citing works
Reproducibility: Respect Your Cells!
Baker, M. (2016) · Nature · doi:10.1038/537433a · Cited by 145 · see citing works
Osmolality of mammalian blood and of media for culture of mammalian cells
Waymouth, C. (1970) · In Vitro · doi:10.1007/bf02616113 · Cited by 140 · see citing works
Terminology associated with cell, tissue and organ culture, molecular biology and molecular genetics
Schaffer, W. I. (1990) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02624162 · Cited by 133 · see citing works
Pamies, D. (2018) · ALTEX · doi:10.14573/altex.1710081 · Cited by 127 · see citing works
Self-citationInitiative, T. I. S. C., Allison, T. F., Andrews, P. W., Avior, Y., Barbaric, I., Benvenisty, N., Bock, C., Brehm, J. L., Brüstle, O., Damjanov, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04011-3 · Cited by 126 · see citing works
Mabry, K. M., Payne, S. Z., & Anseth, K. S. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.035 · Cited by 124 · see citing works
(2011) · Methods in molecular biology · doi:10.1007/978-1-61779-080-5 · Cited by 122 · see citing works
Transient and stable vector transfection: Pitfalls, off-target effects, artifacts
Stepanenko, A. A., & Heng, H. H. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.05.002 · Cited by 115 · see citing works
Zeeberg, B. R., Riss, J., Kane, D. W., Bussey, K. J., Uchio, E., Linehan, W. M., Barrett, J. C., & Weinstein, J. N. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-80 · Cited by 110 · see citing works
Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions
Hendriks, W. T., Warren, C. R., & Cowan, C. A. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2015.12.002 · Cited by 110 · see citing works
ECVAM Good Cell Culture Practice Task Force Report 1
Härtung, T., Balls, M., Bardouille, C., Blanck, O., Coecke, S., Gstraunthaler, G. J. A., & Lewis, D. (2002) · Alternatives to Laboratory Animals · doi:10.1177/026119290203000404 · Cited by 109 · see citing works
Dirks, W. G., MacLeod, R. A. F., Nakamura, Y., Kohara, A., Reid, Y., Milch, H., Drexler, H. G., & Mizusawa, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.24999 · Cited by 104 · see citing works
Observations on intrauterine oxygen tension measured by fibre-optic microsensors
Ottosen, L. D., Hindkjær, J., Husth, M., Petersen, D. E., Kirk, J., & Ingerslev, H. J. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61443-5 · Cited by 95 · see citing works
Concerns, challenges and promises of high-content analysis of 3D cellular models
Carragher, N. O., Piccinini, F., Tesei, A., Trask, O. J., Bickle, M., & Horváth, P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.99 · Cited by 94 · see citing works
Human stem cell–derived astrocytes replicate human prions in a PRNP genotype–dependent manner
Krejciova, Z., Alibhai, J. D., Zhao, C. N., Krencik, R., Rzechorzek, N. M., Ullian, E. M., Manson, J. C., Ironside, J. W., Head, M. W., & Chandran, S. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161547 · Cited by 92 · see citing works
Sources of error in the retracted scientific literature
Casadevall, A., Steen, R. G., & Fang, F. C. (2014) · The FASEB Journal · doi:10.1096/fj.14-256735 · Cited by 89 · see citing works
Best practices for cryopreserving, thawing, recovering, and assessing cells
Baust, J. M., Campbell, L. H., & Harbell, J. W. (2017) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-017-0201-y · Cited by 89 · see citing works
Schildknecht, S. (2013) · ALTEX · doi:10.14573/altex.2013.4.427 · Cited by 85 · see citing works
Morris, G. J. (2005) · Cryobiology · doi:10.1016/j.cryobiol.2005.01.005 · Cited by 81 · see citing works
Higher-Density Culture in Human Embryonic Stem Cells Results in DNA Damage and Genome Instability
Jacobs, K., Zambelli, F., Mertzanidou, A., Smolders, I., Geens, M., Nguyen, H. T., Barbé, L., Sermon, K., & Spits, C. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.01.015 · Cited by 80 · see citing works
Contaminated liquid nitrogen vapour as a risk factor in pathogen transfer
Grout, B. W. W., & Morris, G. J. (2009) · Theriogenology · doi:10.1016/j.theriogenology.2008.12.011 · Cited by 79 · see citing works
HFRS OUTBREAK ASSOCIATED WITH LABORATORY RATS IN UK
Lloyd, G., Bowen, E. T. W., Jones, N., & Pendry, A. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91413-2 · Cited by 78 · see citing works
https://www.altex.org/index.php/altex/article/view/1339
Krebs, A., Waldmann, T., Wilks, M. F., van Vugt-Lussenburg, B. M. A., van der Burg, B., Terron, A., Steger-Hartmann, T., Ruegg, J., Rovida, C., Pedersen, E., et al. (2019) · ALTEX · doi:10.14573/altex.1909271 · Cited by 77 · see citing works
The Role of Hypoxia in Stem Cell Potency and Differentiation
Hawkins, K. E., Sharp, T. V., & McKay, T. R. (2013) · Regenerative Medicine · doi:10.2217/rme.13.71 · Cited by 74 · see citing works
Assou, S., Bouckenheimer, J., & De Vos, J. (2018) · Stem Cells · doi:10.1002/stem.2797 · Cited by 74 · see citing works
Chapter 4 Cell Culture Contamination: Sources, Consequences, Prevention, and Elimination
Lincoln, C. K., & Gabridge, M. G. (1998) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61571-x · Cited by 73 · see citing works
Banking Human Induced Pluripotent Stem Cells: Lessons Learned from Embryonic Stem Cells?
Stacey, G. N., Crook, J. M., Hei, D. J., & Ludwig, T. E. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.09.007 · Cited by 72 · see citing works
RNAi-mediated antiviral immunity in mammals
Berkhout, B. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.07.008 · Cited by 72 · see citing works
Mouse-adapted sporadic human Creutzfeldt–Jakob disease prions propagate in cell culture
Lawson, V., Vella, L. J., Stewart, J., Sharples, R. A., Klemm, H. M. J., Machalek, D. A., Masters, C. L., Cappai, R., Collins, S. J., & Hill, A. F. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.05.024 · Cited by 71 · see citing works
Stacey, G. N. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-080-5_7 · Cited by 66 · see citing works
Standardization of pluripotent stem cell cultures for toxicity testing
Pistollato, F., Bremer‐Hoffmann, S., Healy, L. E., Young, L., & Stacey, G. N. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.639763 · Cited by 66 · see citing works
hPSCreg—the human pluripotent stem cell registry
Seltmann, S., Lekschas, F., Müller, R., Stachelscheid, H., Bittner, M.-S., Zhang, W., Kidane, L., Seriola, A., Veiga, A., Stacey, G. N., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv963 · Cited by 61 · see citing works
Best practices for media selection for Mammalian cells
Price, P. J. (2017) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-017-0186-6 · Cited by 60 · see citing works
Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies
Scarfe, L., Brillant, N., Kumar, J. D., Ali, N., Alrumayh, A., Amali, M. O., Barbellion, S., Jones, V., Niemeijer, M., Potdevin, S., et al. (2017) · npj Regenerative Medicine · doi:10.1038/s41536-017-0029-9 · Cited by 58 · see citing works
Daily, K., Ho Sui, S. J., Schriml, L. M., Dexheimer, P. J., Salomonis, N., Schroll, R., Bush, S., Keddache, M., Mayhew, C., Lotia, S., et al. (2017) · Scientific Data · doi:10.1038/sdata.2017.30 · Cited by 57 · see citing works
Blázquez-Prunera, A., Díez, J. M., Gajardo, R., & Grancha, S. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0552-z · Cited by 55 · see citing works
Scientific considerations for the regulatory evaluation of cell therapy products
Petricciani, J. C., Hayakawa, T., Stacey, G. N., Trouvin, J., & Knežević, I. (2017) · Biologicals · doi:10.1016/j.biologicals.2017.08.011 · Cited by 54 · see citing works
A call for standardized naming and reporting of human ESC and iPSC lines.
Luong, M. X., Auerbach, J., Crook, J. M., Daheron, L., Hei, D., Lomax, G., Loring, J. F., Ludwig, T., Schlaeger, T. M., Smith, K. P., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.03.002 · Cited by 53 · see citing works
Good cell culture practices & in vitro toxicology
Eskes, C., Boström, A.-C., Bowe, G., Coecke, S., Hartung, T., Hendriks, G., Pamies, D., Piton, A., & Rovida, C. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.04.022 · Cited by 52 · see citing works
Self-citationAlternatives to the use of fetal bovine serum: Serum-free cell culture
Gstraunthaler, G. (2003) · ALTEX · doi:10.14573/altex.2003.4.257 · Cited by 51 · see citing works
O'Shea, O., Steeg, R., Chapman, C., Mackintosh, P., & Stacey, G. N. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101773 · Cited by 50 · see citing works
Chan, K. K., Wu, S. M., Nissom, P. M., Oh, S. K. W., & Choo, A. B. H. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0233 · Cited by 48 · see citing works
A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells
Kurtz, A., Seltmann, S., Bairoch, A., Bittner, M.-S., Bruce, K., Capes-Davis, A., Clarke, L., Crook, J. M., Daheron, L., Dewender, J., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.12.002 · Cited by 46 · see citing works
Incidences of problematic cell lines are lower in papers that use RRIDs to identify cell lines
Babic, Z., Capes-Davis, A., Martone, M. E., Bairoch, A., Ozyurt, I. B., Gillespie, T. H., & Bandrowski, A. E. (2019) · eLife · doi:10.7554/elife.41676 · Cited by 44 · see citing works
Detection of EBV, HBV, HCV, HIV-1, HTLV-I and -II, and SMRV in Human and Other Primate Cell Lines
Uphoff, C. C., Denkmann, S. A., Steube, K. G., & Drexler, H. G. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/904767 · Cited by 41 · see citing works
Frommer, W., Archer, L., Boon, B., Brunius, G., Collins, C. H., Crooy, P., Doblhoff‐Dier, O., Donikian, R., Economidis, J., Frontali, C., et al. (1993) · Applied Microbiology and Biotechnology · doi:10.1007/bf00228597 · Cited by 41 · see citing works
Concise Review: The Role of Oxygen in Hematopoietic Stem Cell Physiology
Jež, M., Rožman, P., Ivanović, Z., & Bas, T. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24953 · Cited by 41 · see citing works
Angel, S., von Briesen, H., Oh, Y.-J., Baller, M. K., Zimmermann, H., & Germann, A. (2016) · Biopreservation and Biobanking · doi:10.1089/bio.2016.0046 · Cited by 41 · see citing works
Access to human tissues for research and product development
Pirnay, J., Baudoux, É., Cornu, O., Delforge, A., Delloye, C., Guns, J., Heinen, E., den Abbeel, E. V., Vanderkelen, A., Geyt, C. V., et al. (2015) · EMBO Reports · doi:10.15252/embr.201540070 · Cited by 37 · see citing works
Rebuzzini, P., Zuccotti, M., Redi, C. A., & Garagna, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2171-8 · Cited by 36 · see citing works
Pamies, D. (2020) · ALTEX · doi:10.14573/altex.2007091 · Cited by 35 · see citing works
Self-citationWong, M. K., Li, E. W., Adam, M., Selvaganapathy, P. R., & Raha, S. (2020) · Molecular Human Reproduction · doi:10.1093/molehr/gaaa018 · Cited by 35 · see citing works
The Culture of Cell Culture Practices and Authentication—Results from a 2015 Survey
Freedman, L. P., Gibson, M. C., Wisman, R., Ethier, S. P., Soule, H. R., Reid, Y. A., & Neve, R. M. (2015) · BioTechniques · doi:10.2144/000114344 · Cited by 31 · see citing works
Good Cell Culture Practice for stem cells and stem-cell-derived models
Pamies, D. (2016) · ALTEX · doi:10.14573/altex.1607121 · Cited by 28 · see citing works
Self-citationHantavirus outbreak associated with laboratory rats in Yunnan, China
Zhang, Y., Zhang, H., Dong, X.-Q., Yuan, J., Zhang, H., Yang, X., Zhou, P., Ge, X., Li, Y., Wang, L., et al. (2010) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2010.03.015 · Cited by 26 · see citing works
Cytotoxic Effects of Four Antibiotics on Endothelial Cells
Lanbeck, P., & Paulsen, O. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb01043.x · Cited by 26 · see citing works
Virus zoonoses and their potential for contamination of cell cultures.
Mahy, B. W. J., Dykewicz, C. A., Fisher‐Hoch, S. P., Ostroff, S. M., Tipple, M. A., & Sanchez, A. (1991) · PubMed · Cited by 25 · see citing works
Screening human cell lines for viral infections applying RNA-Seq data analysis
Uphoff, C. C., Pommerenke, C., Denkmann, S. A., & Drexler, H. G. (2019) · PLOS ONE · doi:10.1371/journal.pone.0210404 · Cited by 24 · see citing works
Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing
Stacey, G. N., Coecke, S., Price, A., Healy, L. E., Jennings, P., Wilmes, A., Pinset, C., Ingelman‐Sundberg, M., Louisse, J., Haupt, S., et al. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-33826-2_11 · Cited by 22 · see citing works
Academic application of Good Cell Culture Practice for induced pluripotent stem cells
Tigges, J. (2021) · ALTEX · doi:10.14573/altex.2101221 · Cited by 20 · see citing works
Reduced Aβ secretion by human neurons under conditions of strongly increased BACE activity
Scholz, D., Chernyshova, Y., Ückert, A., & Leist, M. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14467 · Cited by 18 · see citing works
Best practices for the use and evaluation of animal serum as a component of cell culture medium
Nims, R. W., & Harbell, J. W. (2017) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-017-0184-8 · Cited by 17 · see citing works
Food for thought … on education in alternative methods in toxicology
Härtung, T. (2009) · ALTEX · doi:10.14573/altex.2009.4.255 · Cited by 16 · see citing works
From One-Cell to Tissue: Reprogramming, Cell Differentiation and Tissue Engineering
Zhang, D., & Jiang, W. (2015) · BioScience · doi:10.1093/biosci/biv016 · Cited by 16 · see citing works
Proliferation characteristics of cells cultured under periodic versus static conditions
Gilbert, D. F., Mofrad, S. A., Friedrich, O., & Wiest, J. (2018) · Cytotechnology · doi:10.1007/s10616-018-0263-z · Cited by 16 · see citing works
Physiologic expansion of human heart-derived cells enhances therapeutic repair of injured myocardium
Mount, S., Kanda, P., Parent, S., Khan, S., Michie, C., Davila, L., Chan, V., Davies, R. A., Haddad, H. A., Courtman, D. W., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1418-3 · Cited by 16 · see citing works
Baumstummler, A., Chollet, R., Meder, H., Rofel, C., Venchiarutti, A., & Ribault, S. (2010) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2010.02952.x · Cited by 13 · see citing works
Short-Term Effects of Four Antibiotics on DNA Synthesis in Endothelial CellsNote
Lanbeck, P., & Paulsen, O. (2001) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2001.d01-105.x · Cited by 13 · see citing works
Cell Lines: Applications and Biosafety
Stacey, G., & Hawkins, J. R. (2016) · ASM Press eBooks · doi:10.1128/9781555819637.ch14 · Cited by 12 · see citing works
Cytogenetic Analysis of Cell Lines
MacLeod, R. A. F., & Drexler, H. G. (2004) · Humana Press eBooks · doi:10.1385/1-59259-838-2:051 · Cited by 12 · see citing works
(2016) · ASM Press eBooks · doi:10.1128/9781555819637 · Cited by 12 · see citing works
Fundamental Points to Consider in the Cryopreservation and Shipment of Cells for Human Application
Stacey, G., Healy, L. E., Man, J., Hunt, C. J., & Morris, J. M. (2016) · Wiley eBooks · doi:10.1002/9781118743362.ch6 · Cited by 11 · see citing works
Best practices for naming, receiving, and managing cells in culture
Reid, Y. A. (2017) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-017-0199-1 · Cited by 11 · see citing works
Risk Assessment of Cell Culture Procedures
Stacey, G. (2007) · doi:10.1002/9780470723791.ch31 · Cited by 10 · see citing works
Assessing and Controlling Microbial Contamination in Cell Cultures
Coté, R. J. (1999) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0105s01 · Cited by 8 · see citing works
Vracko, R., McFarland, B. H., & Pecoraro, R. E. (1983) · In Vitro · doi:10.1007/bf02619598 · Cited by 5 · see citing works
CULTURE CHARACTERISTICS OF HUMAN FIBROBLASTS PROPAGATED SERIALLY
SWIM, H. E., & PARKER, R. F. (1957) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119897 · Cited by 4 · see citing works
Kleensang, A., Vantangoli, M. M., Odwin-DaCosta, S., Andersen, M. E., Boekelheide, K., Bouhifd, M., Fornace, A. J., Li, H., Livi, C. B., Madnick, S. J., et al. (2016) · Scientific Reports · doi:10.1038/srep33011 · Cited by 4 · see citing works
Darou, S., Henn, A. D., Alm, K., Frank, A. M., & Yerden, R. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-2157 · Cited by 3 · see citing works
Chan, K. K., Wu, S. M., Nissom, P. M., et al. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0233 · Cited by 3 · see citing works
The effect of CO<sub>2</sub>concentration in neuroectoderm commitment of mouse embryonic stem cells
Pamies, D., Vicente-Salar, N., Sogorb, M. A., & Roche, E. (2013) · Journal of Histotechnology · doi:10.1179/2046023612y.0000000018 · Cited by 1 · see citing works
Self-citationStrategy to replace animal-derived ECM by a modular and highly defined matrix
Nesterenko, Y. (2020) · ALTEX · doi:10.14573/altex.2003181 · Cited by 1 · see citing works
Barbero (2014) · doi:10.1016/j · Cited by 1 · see citing works
Availability, Standardization and Safety of Human Cells and Tissues for Drug Screening and Testing
Stacey, G. N., & Hartung, T. (2006) · Drug Testing in vitro · doi:10.1002/9783527609611.ch9
(2018) · Digital Commons@Becker (Washington University School of Medicine) · doi:10.1371/journal
Flagged first, then by citations
Research works printed but not linked: 4
- Adler, S., Allsopp, T., Bremer, S. et al. (2007). hESC technology for toxicology and drug development: Summary of current status and recommendations for best practice and standardization. The Report and Recommendations of an ECVAM Workshop. http://ecvam.jrc.it/publication/hESC\_%20010711.pdf
- NCCUSL - National Conference of Commissioners on Uniform State Laws (2006). Revised Uniform Anatomical Gift Act (2006). Uniform Law Commission. https://bit.ly/3IN4lkE
- SaBTO (2014). Donation of Starting Material for Cell-Based Advanced Therapies: A SaBTO Review. Advisory Committee on the Safety of Blood Tissues and Organs. Department of Health and Social Care.
- Wenger, R. H., Kurtcuoglu, V., Scholz, C. C. et al. (2015). Fre- quently asked questions in hypoxia research. Hypoxia (Auckl) 3 , 35-43. doi:10.2147/HP.S9219 · DOI
Cited by
Sorted by citations
New approach methodologies in human regulatory toxicology – Not if, but how and when!
Schmeisser, S., Miccoli, A., von Bergen�, M., Berggren, E., Braeuning, A., Busch, W., Desaintes, C., Gourmelon, A., Grafström, R., Harrill, J., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108082 · Cited by 409 · see citing works
Organoid intelligence (OI): the new frontier in biocomputing and intelligence-in-a-dish
Smirnova, L., Caffo, B. S., Gracias, D. H., Huang, Q., Pantoja, I. E. M., Tang, B., Zack, D. J., Berlinicke, C. A., Boyd, J. L., Harris, T. D., et al. (2023) · Frontiers in Science · doi:10.3389/fsci.2023.1017235 · Cited by 290 · see citing works
Quality and Safety Considerations for Therapeutic Products Based on Extracellular Vesicles
Takakura, Y., Hanayama, R., Akiyoshi, K., Futaki, S., Hida, K., Ichiki, T., Ishii‐Watabe, A., Kuroda, M., Maki, K., Miura, Y., et al. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03757-4 · Cited by 192 · see citing works
A Beginner’s Guide to Cell Culture: Practical Advice for Preventing Needless Problems
Weiskirchen, S., Schröder, S. K., Buhl, E. M., & Weiskirchen, R. (2023) · Cells · doi:10.3390/cells12050682 · Cited by 148 · see citing works
Papamichail, L., Koch, L. S., Veerman, D., Broersen, K., & van der Meer, A. D. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1515340 · Cited by 120 · see citing works
Development of a Roadmap for Action on New Approach Methodologies in Risk Assessment
Escher, S. E., Partosch, F., Konzok, S., Jennings, P., Luijten, M., Kienhuis, A. S., de Leeuw, V. C., Reuss, R., Lindemann, K.-M., & Bennekou, S. H. (2022) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2022.en-7341 · Cited by 108 · see citing works
Pamies, D., Ekert, J., Zurich, M.-G., Frey, O., Werner, S., Piergiovanni, M., Freedman, B. S., Keong Teo, A. K., Erfurth, H., Reyes, D. R., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.03.009 · Cited by 66 · see citing works
Self-citationMagurany, K. A., Chang, X., Clewell, R. A., Coecke, S., Haugabrooks, E. M., & Marty, S. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad012 · Cited by 58 · see citing works
Tal, T., Myhre, O., Fritsche, E., Rüegg, J., Craenen, K., Aiello-Holden, K., Agrillo, C., Babin, P. J., Escher, B. I., Dirven, H., et al. (2024) · Frontiers in Toxicology · doi:10.3389/ftox.2024.1359507 · Cited by 58 · see citing works
Cultivated meat microbiological safety considerations and practices
Powell, D. J., Li, D., Smith, B. P. C., & Chen, W. N. (2024) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70077 · Cited by 55 · see citing works
Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation
Koch, K., Bartmann, K., Hartmann, J., Kapr, J., Klose, J., Kuchovská, E., Pahl, M., Schlüppmann, K., Zühr, E., & Fritsche, E. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.816370 · Cited by 48 · see citing works
Application of toxicology in silico methods for prediction of acute toxicity (LD50) for Novichoks
Noga, M., Michalska, A., & Jurowski, K. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03507-2 · Cited by 43 · see citing works
The use of NAMs and omics data in risk assessment
Miccoli, A., Marx‐Stoelting, P., & Braeuning, A. (2022) · EFSA Journal · doi:10.2903/j.efsa.2022.e200908 · Cited by 41 · see citing works
Ali, A. S. M., Wu, D., Bannach‐Brown, A., Dhamrait, D., Berg, J., Tolksdorf, B., Lichtenstein, D., Dressler, C., Braeuning, A., Kurreck, J., et al. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.100991 · Cited by 41 · see citing works
Organoid intelligence (OI) – The ultimate functionality of a brain microphysiological system
Smirnova, L. (2023) · ALTEX · doi:10.14573/altex.2303261 · Cited by 40 · see citing works
Metabolomics in Preclinical Drug Safety Assessment: Current Status and Future Trends
Sillé, F. C. M., & Härtung, T. (2024) · Metabolites · doi:10.3390/metabo14020098 · Cited by 38 · see citing works
Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity
Pamies, D., Wiersma, D., Katt, M. E., Zhao, L., Burtscher, J., Harris, G., Smirnova, L., Searson, P. C., Härtung, T., & Högberg, H. T. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105719 · Cited by 37 · see citing works
Self-citationLiu, M., Xiao, R., Li, X., Zhao, Y., & Huang, J.-H. (2025) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70078 · Cited by 36 · see citing works
The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing
Högberg, H. T., & Smirnova, L. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.808620 · Cited by 36 · see citing works
Polit, L. D., Eidhof, I., McNeill, R. V., Warre-Cornish, K. M., Ohki, C. M. Y., Walter, N. M., Sala, C., Verpelli, C., Radtke, F., Galderisi, S., et al. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.101125 · Cited by 32 · see citing works
Romero, J. C., Berlinicke, C. A., Chow, S., Duan, Y., Wang, Y., Chamling, X., & Smirnova, L. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1094291 · Cited by 31 · see citing works
A call for a Human Exposome Project
Härtung, T. (2023) · ALTEX · doi:10.14573/altex.2301061 · Cited by 33 · see citing works
Bridgeman, L., Pamies, D., & Frangiamone, M. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.139562 · Cited by 28 · see citing works
Self-citationThe miniaturized enzyme-modified comet assay for genotoxicity testing of nanomaterials
Yamani, N. E., Rundén‐Pran, E., Collins, A. R., Longhin, E., Elje, E., Hoet, P., Vrček, I. V., Doak, S. H., Fessard, V., & Dušinská, M. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.986318 · Cited by 28 · see citing works
Stem cell therapies for diabetes
Chen, J. T., Dadheech, N., Tan, E. H. P., Ng, N. H. J., Koh, M., Shapiro, A. M. J., & Teo, A. K. K. (2025) · Nature Medicine · doi:10.1038/s41591-025-03767-8 · Cited by 26 · see citing works
Schnur, S., Wahl, V., Metz, J. K., Gillmann, J., Hans, F., Rotermund, K., Zäh, R., Brück, D. A., Schneider, M., & Hittinger, M. (2022) · In vitro models · doi:10.1007/s44164-022-00035-8 · Cited by 23 · see citing works
Carnesecchi, E., Langezaal, I., Browne, P., Leite, S. B., Campia, I., Coecke, S., Dagallier, B., Deceuninck, P., Dorne, J. L. C., Tarazona, J. V., et al. (2023) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2023.105426 · Cited by 20 · see citing works
Renner, N., Schob, F., Pape, R., Suciu, I., Spreng, A., Ückert, A., Cöllen, E., Bovio, F., Chilian, B., Bauer, J., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103165 · Cited by 18 · see citing works
Human brain microphysiological systems in the study of neuroinfectious disorders
Barreras, P., Pamies, D., Härtung, T., & Pardo, C. A. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114409 · Cited by 17 · see citing works
Self-citationAuthor Guide for Addressing Animal Methods Bias in Publishing
Krebs, C. E., Camp, C., Constantino, H., Courtot, L., Kavanagh, O., McCarthy, J., Ort, M., Sarasija, S., & Trunnell, E. R. (2023) · Advancement of science · doi:10.1002/advs.202303226 · Cited by 13 · see citing works
Parvatam, S., Pamies, D., Pistollato, F., Beken, S., Mariappan, I., Roth, A. B., Piergiovanni, M., Maisonneuve, B. G. C., Ewart, L. C., Majumder, A., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.11.008 · Cited by 17 · see citing works
Self-citationSillé, F. C. M., Busquet, F., Fitzpatrick, S., Herrmann, K., Leenhouts-Martin, L., Luechtefeld, T., Maertens, A., Miller, G. W., Smirnova, L., Tsaioun, K., et al. (2024) · ALTEX · doi:10.14573/altex.2407081 · Cited by 15 · see citing works
Reporting In Vitro Experiments Responsibly – the RIVER RecommendationsPreprint
The RIVER working group (2023) · doi:10.31222/osf.io/x6aut · Cited by 16 · see citing works
Aspiroz, L. S., Mennecozzi, M., Batlle‐Morera, L., Corneo, B., Healy, L. E., Kotter, M., Kurtz, A., Ludwig, T. E., Mummery, C. L., Pera, M. F., et al. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102531 · Cited by 16 · see citing works
60 Years of the 3Rs symposium: Lessons learned and the road ahead
Balls, M., Baß, R., Curren, R. D., helen, F. J., Goldberg, A. M., Härtung, T., Herrmann, K., Kleinstreuer, N., Libowitz, L. A., Parascandola, J., et al. (2024) · ALTEX · doi:10.14573/altex.2403061 · Cited by 14 · see citing works
Ito, Y., Kawauchi, I., Yanagita, Y., Sakai, Y., Nishikawa, M., Arakawa, H., Kadoguchi, M., Tamai, I., Esashika, K., Takahashi, J., et al. (2024) · Emergent Materials · doi:10.1007/s42247-024-00822-x · Cited by 12 · see citing works
Canet, G., Rocaboy, E., Laliberté, F., Boscher, E., Guisle, I., Diego-Diàz, S., Fereydouni-Forouzandeh, P., Whittington, R. A., Hébert, S. S., Pernet, V., et al. (2023) · Experimental Neurobiology · doi:10.5607/en23025 · Cited by 11 · see citing works
Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells
Pistollato, F., Bal-Price, A., Coecke, S., Parvatam, S., Pamies, D., Czysz, K., Hao, J., Kee, K., Teo, A. K. K., Niu, S., et al. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.06.003 · Cited by 10 · see citing works
Self-citationNunes, C., Proença, S., Ambrosini, G., Pamies, D., Thomas, A., Kramer, N. I., & Zurich, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1248882 · Cited by 9 · see citing works
Self-citationFood safety of fermented proteins and cultivated meat and seafood
Ong, K. J., Case, F., & Shatkin, J. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18767-4.00033-0 · Cited by 9 · see citing works
Confronting the bias towards animal experimentation (animal methods bias)
Krebs, C. E., & Herrmann, K. (2024) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2024.1347798 · Cited by 9 · see citing works
Navigating stem cell culture: insights, techniques, challenges, and prospects
Górska, A., Trubalski, M., Borowski, B., Brachet, A., Szymańczyk, S., & Markiewicz, R. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1435461 · Cited by 10 · see citing works
Lee, H. J., Yoon, H.-J., & Lee, S. (2025) · Food Research International · doi:10.1016/j.foodres.2025.116204 · Cited by 9 · see citing works
Differentiation and Subculturing of Renal Proximal Tubular‐like Cells Derived from Human iPSC
Meijer, T., Naderlinger, E., Jennings, P., & Wilmes, A. (2023) · Current Protocols · doi:10.1002/cpz1.850 · Cited by 9 · see citing works
Leite, S. B., Brooke, M., Carusi, A., Collings, A., Deceuninck, P., Dechamp, J.-F., Dekker, B. A., Ranieri, E. D., Ganley, E., Gastaldello, A., et al. (2023) · doi:10.31219/osf.io/x85gh · Cited by 9 · see citing works
Self-citationWeener, H. J., Middelkamp, H. H. T., & Van der Meer, A. D. (2024) · Frontiers in Toxicology · doi:10.3389/ftox.2024.1513002 · Cited by 8 · see citing works
Holzer, A.-K. (2023) · ALTEX · doi:10.14573/altex.2310021 · Cited by 8 · see citing works
Cannabidiol protects mouse hippocampal neurons from neurotoxicity induced by amyloid β-peptide25–35
Salgado, K. D. C. B., Nascimento, R. G. D. F., Coelho, P. J. F. N., Oliveira, L. A. M., & Nogueira, K. D. O. P. C. (2024) · Toxicology in Vitro · doi:10.1016/j.tiv.2024.105880 · Cited by 8 · see citing works
An HLA-homozygous haplobank resource to promote safer cell therapies
Stacey, G. N. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.01.003 · Cited by 8 · see citing works
Genetic Characterization of Rat Hepatic Stellate Cell Line PAV-1
Gäberlein, K., Schröder, S. K., Nanda, I., Steinlein, C., Haaf, T., Buhl, E. M., Sauvant, P., Sapin, V., Abergel, A., & Weiskirchen, R. (2023) · Cells · doi:10.3390/cells12121603 · Cited by 8 · see citing works
Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology
Piergiovanni, M., Mennecozzi, M., Barale-Thomas, E., Danovi, D., Dunst, S., Egan, D., Fassi, A., Hartley, M., Kainz, P., Koch, K., et al. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03922-z · Cited by 7 · see citing works
“Comple-mentarily, Good Cell Culture Practices (Pamies et al. 2022; Pistollato et al. 2022) were also developed by the research community to face challenges of advanced cellular models, including stem cells and organoids (Pamies et al. 2018), MicroPhysiological Systems and Organ-on-Chip (Pamies et al. 2024).”
Systems engineering of microphysiometry
Wiest, J. (2022) · Organs-on-a-Chip · doi:10.1016/j.ooc.2022.100016 · Cited by 7 · see citing works
Baraka, S., Sam, A., Krysmann, M. J., Cook, N., Ahmed, W., & Barrak, F. (2025) · BDJ Open · doi:10.1038/s41405-025-00293-0 · Cited by 6 · see citing works
Cöllen, E., Tanaskov, Y., Holzer, A., Dipalo, M., Schäfer, J., Kraushaar, U., & Leist, M. (2024) · ALTEX · doi:10.14573/altex.2401041 · Cited by 6 · see citing works
Pinto, M. B., Pires, P. C., Correia, M., Moço, G., Sousa‐Oliveira, I., Sousa, M. J., Calhelha, R. C., Vilas‐Boas, M., Falcão, S. I., Mazzola, P. G., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00253 · Cited by 5 · see citing works
Microphysiological systems as a pillar of the Human Exposome Project
Sillé, F. C. M., Smirnova, L., & Härtung, T. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110782 · Cited by 5 · see citing works
Dissection of Neurochemical Pathways Across Complexity and Scale
Abbondanza, A., Kim, N., Lima‐Filho, R. A. S., Amin, A., Anversa, R. G., Almeida, F. B., Cardozo, P. L., Carello‐Collar, G., Carsana, E. V., Folarin, R. O., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70160 · Cited by 4 · see citing works
Simon, S., Shanmugalingam, T., Neu, T., Schneider‐Daum, N., Cantrill, C., & Lehr, C. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107333 · Cited by 4 · see citing works
Arroyo-Xochihua, O., Zepeda, R. C., & Sánchez-Medina, A. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05038-w · Cited by 4 · see citing works
Liu, Y., Balaji, R., Toledo, M. A. S., Ernst, S., Hautvast, P. A. I., Kesdoğan, A. B., Körner, J., Zenke, M., Neureiter, A., & Lampert, A. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-02945-w · Cited by 4 · see citing works
Strategies for the Establishment of Fibroblastic Lines for the Conservation of Wild Mammals
Pereira, A. F., de Oliveira, L. R. M., de Aquino, L. V. C., Viana, J. V. D. S., & Rodrigues, L. L. V. (2023) · Veterinary medicine and science · doi:10.5772/intechopen.114028 · Cited by 4 · see citing works
Research reporting guidelines for cell lines: more than just a recommendation
Weiskirchen, R. (2023) · Annals of Translational Medicine · doi:10.21037/atm-23-1208 · Cited by 4 · see citing works
Ding, L., Moser, M., Zhang, W., & Hu, N. (2025) · Results in Engineering · doi:10.1016/j.rineng.2025.107010 · Cited by 3 · see citing works
Apostolidi, A., Stergiopoulos, G., Bellou, S., Μάρκου, Μ., Fotsis, T., Murphy, C., & Bagli, E. (2025) · Pharmaceuticals · doi:10.3390/ph18091374 · Cited by 3 · see citing works
Klima, S., Hurrell, T., Goolam, M., Gouws, C., Engelbrecht, A., Kaur, M., & van den Bout, I. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102391 · Cited by 3 · see citing works
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants
Staal, Y. C. M., Geraets, L., Rothen‐Rutishauser, B., Clift, M. J. D., Braakhuis, H., Kienhuis, A. S., & Bos, P. M. J. (2023) · ALTEX · doi:10.14573/altex.2305311 · Cited by 3 · see citing works
How Do Microbial Safety Issues Associated With Meat Apply to Cell Cultivated Products?
Food Standards Agency, Romero, R., & Quill, E. (2025) · FSA research and evidence. · doi:10.46756/001c.144237 · Cited by 2 · see citing works
Towards learning and memory risk assessment with human brain organoids: barriers and opportunities
Mohapatra, R., Din, D. A. E., Zhao, H., Härtung, T., & Smirnova, L. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1783893 · Cited by 3 · see citing works
Lim, C. W., Liew, K. Y., Lim, S. H., Cheema, M. S., Sulaiman, P. S., Harith, H. H., Saidi, H. I., & Tham, C. L. (2024) · Education and Information Technologies · doi:10.1007/s10639-024-12696-x · Cited by 2 · see citing works
Brain organoids as a translational model of human developmental neurotoxicity
Härtung, T., Schenke, M., & Smirnova, L. (2024) · Advances in neurotoxicology · doi:10.1016/bs.ant.2024.07.002 · Cited by 2 · see citing works
Characterisation of Primary Human Hippocampal Astrocyte Cell Culture Following Exposure to Hypoxia
Nazli, N. A. N., Muthuraju, S., Ahmad, F., Yusoff, A. A. M., Jaafar, H., Shamsuddin, S., & Abdullah, J. M. (2023) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2023.30.1.8 · Cited by 1 · see citing works
Escobar, A. A. H., Denis, B., Gittens, R. A., & Ibarra-Ramírez, E. A. (2025) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-031-88064-3_5 · Cited by 1 · see citing works
Single-cell omics for nutrition research: an emerging opportunity for human-centric investigations
Cassotta, M., Díaz, Y. A., Cianciosi, D., Yang, B., Qi, Z., Chen, G., Villar, S. G., López, L. A. D., Grosso, G., Quiles, J. L., et al. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2566387 · Cited by 1 · see citing works
Klymenko, Y., Kersey, J. L., Quigley, H. D., & Hawkins, S. M. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf255 · Cited by 1 · see citing works
AI redefine untargeted metabolomics: estimating chemical amounts for a Human Exposome Project
Sillé, F. C. M., Kopańska, K., Prasse, C., Luechtefeld, T. H., & Hartung, T. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1775284 · Cited by 1 · see citing works
A probabilistic and context-dependent cell culture modelling framework for regulatory toxicology
Madorran, E. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1765753 · Cited by 2 · see citing works
Maslennikov, S. O., Isachenko, M. I., Данукало, М. В., Головаха, М. Л., Hancheva, O. V., & Kolesnyk, Y. M. (2026) · Modern medical technology · doi:10.14739/mmt.2026.2.346269 · Cited by 1 · see citing works
New horizons of microphysiological systems: India forging its path in human-relevant research
Parvatam, S., Mahadik, K., Banerjee, A. A., Patil, K., Radha, V., & Rao, M. (2023) · Biology Open · doi:10.1242/bio.059847 · Cited by 1 · see citing works
NAMazing: Déjà Vu at the lab bench - Why animal-free science is the new automobile
Härtung, T. (2025) · NAM journal. · doi:10.1016/j.namjnl.2025.100022 · Cited by 1 · see citing works
Spänle, J. V., Haiber, L. M., & Seeger, B. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1800157 · Cited by 1 · see citing works
CellTox Days 2022 – Inside the barriers: In vitro models and their applications
Steimberg, N. (2023) · ALTEX · doi:10.14573/altex.2211101
Assaying Proliferation Characteristics of Cells Cultured Under Static Versus Periodic Conditions
Gilbert, D. F., Friedrich, O., & Wiest, J. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3052-5_3
Hernández‐Díaz, N., Tzouganatou, S., Mulik, P. R., Balestrini, P. A., & Fogarty, N. M. E. (2024) · Placenta · doi:10.1016/j.placenta.2024.07.308
Exploring Environmental Neurotoxicity Assessment Using Human Stem Cell-Derived Models
Kebieche, N., Ali, F. L., Seungae, Y., Ali, M., Lambert, C., & Soulimani, R. (2024) · Journal of Stem Cell Therapy and Transplantation · doi:10.29328/journal.jsctt.1001044
Standards of Good Practices for the Conduct of In Vitro Toxicity Studies
Ulrey, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00221-7
Truszkowski, L., Bottini, S., Bianchi, S., Scrivano, M. G., Ramondo, G. F., Belluci, L., Bell, H., Becca, S., Snijders, K. E., Savoré, G., et al. (2025) · Open Research Europe · doi:10.12688/openreseurope.18245.2
Scientific Foundations of Plant Propagation
Adel, A. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-5626-6.ch005
Hastilestari, B. R., Khaerani, P. I., Hardiansyah, M. Y., Amas, A. N. K., & Membalik, V. (2026) · Springer eBooks · doi:10.1007/978-981-95-7261-8_20
Siahaan, D. T. A., Alfi, B. R., Mercuriani, I. S., & Pamungkas, R. (2026) · Jurnal Penelitian Pendidikan IPA · doi:10.29303/jppipa.v12i5.11395
Safety Aspects of Cell Culture-Derived Food for Human Consumption
Rivero‐Pino, F., Rueda, D. C., Hee, C. S., Kubinyecz, O., & Lester, H. E. (2026) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2026_333
In vitro alternatives to animal models for the assessment of nanoparticle respiratory toxicity
McAllister, K., Brooks, S., Clift, M. J. D., & Murphy, F. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2698783
The Prospects, Difficulties, and Research Paths for Environmental Toxicology
Ilahi, M., Yogita, Chatterjee, S., & Chakraborty, N. (2026) · Springer eBooks · doi:10.1007/978-3-032-28619-2_11
Alnoubani, Z., Khanafer, Y., Fojnica, A., Begagić, E., Rose, I., Gatalica, Z., & Vranić, S. (2026) · Carcinogenesis · doi:10.1093/carcin/bgag052
Laboratory Setup, Management, and Quality Control
Badal, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-34362-8_2
Staff Training and Competency Development
Badal, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-34362-8_3
Coecke, S., & Hartung, T. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1921273
Sillé, F., Désert, P., Levis, R., Wrzesinski, C., Cavaleri, M., & Hartung, T. (2026) · ALTEX · doi:10.14573/altex.2608271
- Authors
- Pamies, D.
- Affiliations
- Swiss Centre for Applied Human Toxicology (CH)
- Corresponding author
- Pamies, David
- ORCID
- Pamies, David
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2021
- Volume
- 39
- Pages
- 30-70
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W4200063815
- Semantic Scholar
- 7e2fe7256471b28b7018786acb02a87e45b8b6c3
- Cited by
- 100
- References
- 125
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 22 · 2023: 29 · 2022: 10
- FWCI
- 17.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- ALTEX (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, cc-by)
- KOPS (University of Konstanz) (submittedVersion)
- IRIS (submittedVersion, cc-by)
- Radboud Repository (Radboud University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Health Sciences › Medicine › Physiology › Clinical Laboratory Practices and Quality Control
- Keywords
- reproducibility, cell culture model, cell characterization, cell maintenance, laboratory safety, employee training, research ethics, ECVAM
- MeSH terms
- Animals, Animal Testing Alternatives, Laboratories, Reproducibility of Results, Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review